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potential to influence cutaneous biology. While a number of studies have described the importance of these
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in skin inhabitants characterized by decreases in diversity and domination by previously minor contributors.
By contrast, we report a relatively modest impact of antiseptics on skin bacteria, largely preserving inhabitant
structure at the community-level. Despite these differences, we show a significant decrease in Staphylococcus
residents regardless of treatment, a subset of inhabitants which we also found to influence colonization by the
skin pathogen Staphylococcus aureus. To determine the relevance of these findings in human systems, we
further treated thirteen subjects with antiseptics at the forearm and back. Similar to mouse experiments, we
observed a relatively minor effect of these treatments on bacterial inhabitants at the population-level.
However, when controlling for factors such as interindividual differences and body-site specificity, we
observed a more significant impact, governed in large part by decreases in lowly abundant members of the
skin microbiota. We also found bacterial identity to be a key contributor to this effect, with certain skin taxa
exhibiting more robust shifts than others. In all, these results underscore the ability of antimicrobial drugs to
alter skin bacterial residence, and outline the importance of these inhabitants to host cutaneous defense.
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ABSTRACT 
 
IMPACT OF TOPICAL ANTIMICROBIAL TREATMENTS ON  
SKIN BACTERIAL COMMUNITIES 
Adam Jason SanMiguel 
Elizabeth Anne Grice, Ph.D. 
 
Skin is our primary interface to the outside world, representing a diverse habitat 
with a multitude of folds, invaginations, and appendages. While each of these 
structures is essential to host cutaneous function, they also serve as unique 
ecological niches that can support an array of microbial inhabitants. Together, these 
microorganisms constitute the skin microbiome, an assemblage of bacteria, fungi, 
and viruses with the potential to influence cutaneous biology. While a number of 
studies have described the importance of these residents to immune function and 
development, none to date have assessed their dynamics in response to 
antimicrobial stress, nor the impact of these perturbations on host cutaneous 
defense. Rather the majority of work in this regard has focused on a subset of 
microorganisms studied in isolation. Herein, we present the impact of topical 
antibiotics and antiseptics on skin bacterial communities, and describe their 
potential to shape cutaneous interactions. Using mice as a model system, we show 
that antibiotics can elicit a distinct shift in skin inhabitants characterized by 
decreases in diversity and domination by previously minor contributors. By 
 vii 
contrast, we report a relatively modest impact of antiseptics on skin bacteria, largely 
preserving inhabitant structure at the community-level. Despite these differences, 
we show a significant decrease in Staphylococcus residents regardless of treatment, 
a subset of inhabitants which we also found to influence colonization by the skin 
pathogen Staphylococcus aureus. To determine the relevance of these findings in 
human systems, we further treated thirteen subjects with antiseptics at the forearm 
and back. Similar to mouse experiments, we observed a relatively minor effect of 
these treatments on bacterial inhabitants at the population-level. However, when 
controlling for factors such as interindividual differences and body-site specificity, 
we observed a more significant impact, governed in large part by decreases in lowly 
abundant members of the skin microbiota. We also found bacterial identity to be a 
key contributor to this effect, with certain skin taxa exhibiting more robust shifts 
than others. In all, these results underscore the ability of antimicrobial drugs to alter 
skin bacterial residence, and outline the importance of these inhabitants to host 
cutaneous defense. 
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Chapter 1 – Introduction to antimicrobial drugs and the skin 
microbiome  
 
1.1 Historical perspective 
Studies of the skin microbiome have, throughout history, become inextricably linked 
with a desire to remove said inhabitants. This is perhaps best exemplified by early 
reports describing the utility of hygiene and antiseptics under Ignaz Semmelweis 
and Joseph Lister in the mid-1800s1,2. These studies described the potential for 
antibacterial compounds to reduce infection and improve surgical mortality rates, a 
figure well above 10% in developed countries at the time3. While initially 
controversial, antiseptic methods were ultimately accepted by the medical 
community, and heralded as a proficient means to reduce the levels of skin bacterial 
residents with the potential to cause disease4-7. 
 
As time progressed, researchers built upon these studies with a focus on chemicals 
displaying the greatest potential for skin sterilization8,9, hoping to improve upon the 
findings of Semmelweis and Lister. Eventually, however, two factors became 
increasingly apparent in the fight against infection. First, that no technique was 
capable of complete and consistent sterilization of the skin10,11. And second, that 
many of the surviving microorganisms were also known residents of the skin, 
eliciting little detriment in the overall outcome of patients12,13. This newfound 
understanding led to a fundamental shift in the field of skin bacteriology, and, paired 
with the advent of narrow spectrum antibiotics, resulted in experiments focused on 
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the disruption of specific pathogenic microorganisms rather than sterilization of 
entire cutaneous populations14,15.  
 
Since this time, a wealth of literature has described the impact of antibiotics and 
antiseptics on infectious bacteria, underscoring the importance of these drugs to 
human health and disease16-18. However, this focus has also led to constraints in our 
knowledge of resident bacterial response. Indeed, although antimicrobial drugs are 
commonly applied directly to the skin, few studies have assessed their impact 
beyond that of pathogenic microorganisms19. A reliance on culture-based systems 
has further complicated this question, with a true survey of antimicrobial effects 
being all but impossible without prior knowledge of resident growth 
requirements20. This has resulted in an over-simplification of the field, and the 
presumption that effects on easily cultured skin residents can be applied to other 
cutaneous inhabitants21. No study to date has adequately verified this assertion, 
however, leading to conflicting views amongst researchers and physicians alike.   
 
1.2 New technologies to answer an old question 
In light of these shortcomings, we and others have begun to apply less-biased 
methods to the identification of skin bacterial residents. Specifically, the 
introduction of sequencing-based technologies has enabled the study of nearly all 
bacterial inhabitants, rather than limiting researchers to microorganisms with well-
established, culture-based protocols22. These approaches also represent a more 
high-throughput method for bacterial community identification, exhibiting a 
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significant advance on previous strategies which required an abundance of selective 
medias and agars to differentiate between inhabitants23.  
 
Sequencing-based technologies generally fall within two broad categories: marker-
based and whole genome24. As its name would suggest, marker-based methods rely 
on specific genes found throughout the bacterial kingdom to describe community 
membership. Ideally, these genes contain stretches of both conserved and 
hypervariable sequences. This then allows for the design of primers to conserved 
areas, and the use of nearby hypervariable regions to distinguish amongst 
residents25,26. The best example of such markers is the 16S rRNA gene, found 
ubiquitously in bacteria27. This gene contains nine hypervariable regions, each 
representing the opportunity to resolve differences in bacterial membership under 
a variety of conditions. We and others have described the utility of the V1-V3 
hypervariable regions for human skin bacterial identification28. However, other 
regions can also be helpful depending upon the environment to be sampled29.  
 
Despite these advantages, marker-based analyses are not without limitations. 
Specifically, species- and strain-level information can be difficult to extract when 
comparing residents with high proportions of sequence homology. To compensate 
for this restriction, whole genome shotgun sequencing is often employed to acquire 
longer stretches of information30. While more expensive than marker-based 
approaches, this technique allows for higher levels of resolution when attempting to 
distinguish between closely related bacterial inhabitants31. This method is also 
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useful in metagenomic analysis, a type of examination which describes both the 
composition and functional potential of a given community32. Cost can still 
represent a prohibitive variable when making multiple comparisons, however. As 
such, both resolution and price must be weighed appropriately, prior to 
investigation, to maximize the breadth and depth of one’s analyses.  
 
1.3 Study outline and rationale 
With this information in mind, we applied sequencing-based methods to more 
completely evaluate the impact of topical antimicrobial drugs on skin bacterial 
residence. As our experiments represent the first attempts at said endeavors, 
marker-based 16S rRNA gene sequencing was employed for community analyses. 
This enabled us to widen the breadth of our comparisons, and to assess the 
longitudinal dynamics of skin residents in response to multiple treatment regimens.  
 
To control for the greatest number of variables, we began our tests in the murine 
model system. SKH-1 hairless mice were treated at the dorsum with a triple 
antibiotic ointment (Bacitracin, Neomycin, and Polymyxin B) or the narrow 
spectrum antibiotic Mupirocin. Samples were then collected longitudinally to assess 
changes in the skin microbiota over time. Antibiotic treated mice were compared to 
those receiving vehicle ointments to control for non-antibacterial effects. A separate 
cohort was also treated with water or the common clinical antiseptics alcohol (80% 
ethanol) and povidone-iodine (Betadine) to compare mechanistically distinct 
antimicrobial interventions. 
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During these investigations, we observed a conserved ability of all treatments to 
disrupt Staphylococcus skin residence. Because members of this genus have been 
shown to influence colonization by the skin pathogen Staphylococcus aureus33,34, we 
also used our system to interrogate the role of antimicrobial drugs in skin 
colonization resistance. Colonization resistance represents a means for resident 
species to defend a host against more pathogenic microorganisms35. Moreover, in 
the gastrointestinal tract, antibiotic treatment has been shown to increase host 
susceptibility to infection through alterations in resident communities36. We show 
that the skin microbiota functions in a similar manner, with multiple Staphylococcus 
residents representing potential S. aureus competitors at the skin surface. 
 
As a validation of these experiments, our final assessment included an investigation 
of antiseptics and human skin bacterial residents. Previous studies have defined 
these inhabitants as exhibiting high levels of both inter- and intrapersonal 
variability37,38. This includes a distinct stratification of communities by cutaneous 
biogeograpy39. To account for these variables, thirteen subjects were treated 
identically at the back and forearm, body sites with significant topographical 
distinction40. In all, these studies enabled us to evaluate the resilience of human 
bacterial residents at the population-level, and together with our murine 
experiments, expound the importance of key variables to skin bacterial community 
response.  
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Chapter 2 - Interactions between host factors and the skin 
microbiome  
 
The contents of this chapter have been published as: 
SanMiguel A, Grice EA. (2015) Interactions between host factors and the skin 
microbiome. Cell Mol Life Sci. Apr;72(8):1499-515. 
 
2.1 Abstract 
The skin is colonized by an assemblage of microorganisms which, for the most part, 
peacefully coexist with their hosts. In some cases, these communities also provide 
vital functions to cutaneous health through the modulation of host factors. Recent 
studies have illuminated the role of anatomical skin site, gender, age, and the 
immune system in shaping the cutaneous ecosystem. Alterations to microbial 
communities have also been associated with, and likely contribute to, a number of 
cutaneous disorders. This review focuses on the host factors that shape and 
maintain skin microbial communities, and the reciprocal role of microbes in 
modulating skin immunity. A greater understanding of these interactions is critical 
to elucidating the forces that shape cutaneous populations and their contributions 
to skin homeostasis. This knowledge can also inform the tendency of perturbations 
to predispose and/or bring about certain skin disorders. 
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2.2 Introduction 
The skin is our primary interface to the external environment, supporting the 
growth of commensal microorganisms while impeding invasion by more pathogenic 
species. Culture-independent techniques that employ sequencing of marker genes, 
such as the bacterial-specific 16S ribosomal RNA (rRNA) gene, have begun to 
elucidate the community characteristics of these cutaneous microorganisms. In 
addition, these analyses have been used to inform elements of intrapersonal and 
interpersonal variability, as well as longitudinal dynamics of skin microbial 
communities. These studies have also led to investigations into the importance of 
host-microbe interactions, and their ability to shape the identity and composition of 
commensal relationships. This review will highlight these determinants as they 
pertain to a number of host factors. It will also address the role of microbiome-host 
interactions in certain skin disorders. While numerous microorganisms are thought 
to colonize the skin surface, we will emphasize the contribution of bacterial and 
fungal inhabitants. However, it is important to note that viruses, mites, and archaea 
are all capable of influencing residential populations of the skin. 
 
2.3 Cutaneous architecture and biochemistry 
To fully appreciate the microbial diversity of the skin, one must first understand the 
complex architecture and environment of this organ. As a critical barrier to the 
outside world, human skin is essential for activities such as thermoregulation, gas 
exchange, and hydration [1]. It also represents one of the body’s largest and most 
exposed organs with approximately 1.8 m2 of total surface area. The biogeography 
 13
of the skin includes a number of planes, folds, and invaginations, each capable of 
maintaining a unique microenvironment. For this reason, microbial communities 
above the cool, desiccating skin surface often differ greatly from those found within 
shielded pores and follicles [2]. Different skin sites can also contribute to microbial 
heterogeneity through the production of various lipid- and water-based solutions. 
These determinants then work in concert with additional host factors and the 
external environment to shape an individual’s core microbiome.  
 
2.3.1 Skin strata 
Human skin consists of two main layers: the epidermis and the dermis (Figure 1). As 
the most superficial layer, the epidermis contributes the majority of barrier 
functions while the dermis provides a structural framework made of fibrous and 
connective tissues. Underlying these strata is a layer of subcutaneous fat, which is 
critical for the protection of deeper tissues and bones.  
 
As a continually self-renewing epithelium, the epidermis can be subdivided into four 
main strata, characterized by cells at varying stages of development (Figure 1). The 
bottommost layer, the stratum basale, contains a single layer of undifferentiated 
stem cells that rest upon the epidermal basement membrane [3]. All keratinocytes 
originate from these basal cells, and they are essential for the regeneration of 
keratinocytes lost to terminal differentiation and desquamation [4]. During 
asymmetric cell division, these progenitor cells produce a subset of daughter cells 
that exit the cell cycle and separate from the basement membrane to form the 
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stratum spinosum. In this layer, immature keratinocytes are characterized by 
abundant calcium-dependent desmosomes, which promote intercellular adhesion 
and resistance to mechanical stress [5]. As these cells continue to develop, they also 
flatten and initiate the formation of lamellar bodies and keratin filaments to support 
overall skin structure [5]. 
 
Upon further maturation, keratinocytes progress upwards to populate the stratum 
granulosum, so-named for the presence of prominent keratohyalin granules. These 
vesicles contain filaggrin, keratin filaments, loricrin, and involucrin – all necessary 
components for the hydration and structure of mature epidermal tissue [5]. 
Keratinocytes of the stratum granulosum are also held together by a number of 
extracellular tight junction proteins including claudins and occludins, which are 
essential to epidermal barrier function [6]. During the terminal stages of 
differentiation, cells of the granular layer compress and anucleate to form the 
stratum corneum. At this stage, keratinocytes then become known as corneocytes 
for their highly cornified cellular envelopes. These protein-enriched cells are also 
held together by keratins, corneodesmosomes, and a lipid-enriched extracellular 
matrix to provide a strong physical barrier that is resistant to mechanical stress, UV 
damage, and permeation [7].  
 
2.3.2 Appendages 
In addition to these strata, the skin is also characterized by a number of appendages 
that can extend beyond the epidermis into the dermis. These include sebaceous 
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glands, hair follicles, and sweat glands. Sebaceous glands specialize in the secretion 
of sebum, an oily, lipid-rich substance that provides skin flexibility and 
waterproofing. Most sebaceous glands are also connected to hair follicles to form 
pilosebaceous units that concentrate on the face and upper body [8].  Pilosebaceous 
follicles support an array of niche-specific microorganisms that can thrive in anoxic 
environments rich in sebum-derived lipids [9]. These lipids can then be metabolized 
into free fatty acids by bacterial commensals, which contribute to the acidic pH of 
the skin [10]. Importantly, while the number and distribution of sebaceous glands 
remains relatively constant throughout life, their size and activity fluctuates widely 
depending on age and hormone levels [8]. It is thus not surprising that puberty 
marks a defining period in skin development characterized by the elevated 
production of sebum and sebum-related products, as well as the subsequent growth 
of lipophilic skin microbial inhabitants [11].  
 
Sweat glands, another critical appendage of the epidermis, can be divided into two 
major types: apocrine and eccrine. Like sebaceous glands, apocrine sweat glands 
release oily secretions into upper hair follicles and are especially active during 
puberty. Apocrine sweat is composed of a milieu of proteins, lipids and steroids 
[12]. Apocrine glands are also more sparsely distributed, often localized to 
especially pileous regions such as the axillae and perineum [12].  
 
Eccrine sweat glands, in contrast, are widely distributed throughout the body with 
high concentrations at the forehead, axillae, palms, and soles [13]. They are also the 
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only gland with direct access to the skin surface, and as such, continuously bathe the 
epidermis in a water- and salt-based sweat solution. These secretions are critical to 
thermoregulation and hydration, and also contribute to the relatively acidic pH of 
skin surfaces.   
 
In all, the dissemination and activity of epidermal appendages provide essential 
roles for the human body. By creating habitats with unique levels of moisture, pH 
and nutrients, they also represent specialized niches that can promote the growth of 
distinct microbial communities. This then contributes to the unique stratification of 
bacterial populations at skin sites throughout the body.  
 
2.4 Host factors and the skin microbiota 
2.4.1 Topographical variability 
The site-specificity of the skin microbiota has been borne out in multiple 
experiments analyzing unique topographical locations of the skin (Figure 2). For 
example, a study of 20 distinct body sites representing sebaceous, moist, and dry 
physiological environments found that Propionibacterium and Staphylococcus 
species dominated sebaceous skin sites including the face and upper body [14]. By 
contrast Corynebacterium, β-Proteobacteria, and Staphylococcus were the major 
genera at moist sites such as the axilla, antecubital fossae (inner elbow), and 
popliteal fossae (inner knee). Dry sites including the forearm and buttock were 
found to be more variable, supporting the growth of numerous phylotypes including 
β-Proteobacteria, Corynebacterium, and Flavobacteriales.  
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Upon more in-depth analyses, it was revealed that the sites richest in bacterial 
operational taxonomic units (OTUs; a sequence-level proxy for designating species) 
were often dry regions such as the forearm, while sebaceous sites including the 
upper back and retroauricular crease (behind the ear) were home to fewer bacterial 
phylotypes. In addition, sebaceous regions were consistently lower in bacterial 
evenness as measured by the relative distribution of sequences among OTUs. 
Interpersonal variation (differences between individuals) was found to be greater 
than intrapersonal variation (differences within individuals) over time. This 
suggests that individuality and body site physiology are both strong determinants of 
bacterial community membership and structure.  
 
Similarly to above, Costello et al. observed that temporal intrapersonal variability 
was less pronounced than interpersonal variability between individuals [15]. These 
studies also confirmed that spatial intrapersonal variability (e.g. variability in 
microbiomes of distinct body sites such as forehead, arm, and umbilicus) was even 
greater than interpersonal variability at the same skin site. As such, although 
individual microbial populations of the skin are often more similar to themselves in 
regard to symmetry and time, these likenesses appear to breakdown when 
comparing separate biogeographic regions.  
 
In accordance with Grice et al., this group also found high levels of 
Propionibacterium at sebaceous sites on the face, and greater diversity at areas such 
as the popliteal fossa, forearm, and palm. Moreover, it was shown that the variation 
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of these sites remained relatively constant over time, as the palm and forearm were 
both consistently more diverse than the forehead at four separate collection 
periods.   
 
The influence of body site in regard to overall community structure was also tested 
by inoculating bacteria from foreign sites onto new areas of the skin. These studies 
observed a relative flexibility in forearm community membership, while the 
forehead microbiota rapidly returned to a population resembling its native state. 
This suggests that host factors may vary in their ability to promote bacterial 
colonization, especially at sebaceous sites with strong environmental biases.  
 
Whereas these studies sought to compare multiple body sites, additional research 
has focused on individual skin regions. These studies largely complement one 
another, providing greater insight into the contribution of topography to skin 
microbial communities. For example, studies performed on the human forearm have 
illustrated relatively high degrees of bacterial diversity, although this population is 
consistently dominated by Propionibacterium, Corynebacterium, Staphylococcus, 
Streptococcus, and Acinetobacter [14-17]. While these major taxa appear throughout 
the literature, however, it appears that their relative contributions to the forearm 
community can fluctuate greatly.  
 
The same can be said of the palmar region, which is frequently exposed to new 
surfaces and environments - while major phylotypes such as Propionibacterium, 
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Streptococcaceae, and Staphylococcaceae are consistently observed, a great amount 
of variability exists in regard to their absolute numbers and proportions 
[14,15,18,19]. Thus it appears that certain exposed regions including the palm and 
forearm are less restricted in overall community membership and highly 
susceptible to temporal variability.  
 
By contrast, other regions, including those with high sebaceous gland activity, are 
much more exclusive. For example, the forehead harbors fewer bacterial species and 
is largely dominated by Propionibacterium [14,15,17,20]. This observation is 
congruent among multiple studies, and as such, represents a relatively consistent 
trend. Whether this effect is inherent to the lipid-rich environment of the forehead, 
or whether Propionibacterium can successfully restrict membership alone is 
currently unknown. Regardless, this region appears largely invariant compared to 
more diverse sites of the skin, and thus represents a more stable overall community 
structure.  
 
While compelling, the stratification illustrated by certain dry and sebaceous sites is 
by no means absolute, as multiple sites of the skin are characterized by intermediate 
diversity with both dominant and transient taxa [14,15]. Therefore, further research 
will be necessary to determine the role of intrinsic host factors and extrinsic 
microbial traits as they pertain to skin bacterial communities.  
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Recent studies have also begun to elucidate the topographical diversity of fungal 
communities on human skin [21]. Specifically, it was shown that Malassezia 
predominated at core body and arm sites, but that discrete signatures could be 
observed at the species level. For example, the face was dominated by Malassezia 
restricta while the back, occiput (back of neck), and inguinal crease (groin) were all 
characterized by higher levels of Malassezia globosa.  
 
In contrast to these areas, regions of the foot such as the plantar heel, toenail, and 
toe-web space were all defined by significantly greater amounts of fungal diversity. 
While Malassezia was still detected in all samples, subjects were also colonized by 
relatively high proportions of Aspergillus and Epicoccum. Interestingly, regional 
localization was found to be the strongest determinant of fungal community 
membership as feet, arms, the head, and torso all formed distinct communities 
regardless of physiological environment. This suggests that while bacterial 
populations are subject to factors such as sebum content and hydration, fungal 
communities are more flexible in resource utilization, a less surprising realization 
given their pronounced evolutionary differences.  
 
2.4.2 Gender 
The contribution of gender to skin microbial diversity likely arises as a downstream 
effect of male and female steroid production [13]. For example, it is thought that 
androgen expression and identity are both critical to sex-defined differences in skin 
thickness [22,23]. Males also exhibit increased levels of sebaceous and sweat gland 
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activity compared to females, a trait that strongly contributes to differences in skin 
surface biochemistries [24,25]. Even the presence or absence of body hair could 
presumably result in alternative microenvironments with the potential to support 
the growth of niche-specific microorganisms. Interestingly, mixed results have been 
observed in regard to gender and pH. While some studies have detected a more 
acidic pH in female skin, others have demonstrated no differences [26-29]. This 
suggests that variation in male and female physiologies have the potential to 
influence microbial communities, but that certain factors likely contribute to skin 
habitats more strongly than others.  
 
With this in mind, a recent study that sampled the palmar regions of male and 
female undergraduate students observed significantly different bacterial 
communities on the skin surface in regard to gender [18]. While no taxa were 
specific to either sex, there were marked differences in the relative abundances of 
numerous bacterial groups. For example, Propionibacterium and Corynebacterium 
were 37% and 80% more abundant in men, respectively, along with a trend towards 
higher levels of Staphylococcus. By contrast, Enterobacteriales, Moraxellaceae, 
Lactobacillaceae, and Pseudomonadaceae were all over 150% more abundant in 
females. Women were also found to harbor significantly greater levels of alpha 
diversity, a metric that defines “within” sample diversity and is often measured by 
numbers of OTUs, their evenness, and their degree of phylogenetic difference. 
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In contrast to these results, a study of healthy Chinese undergraduates showed no 
significant differences between the palmar bacterial communities of men and 
women [19]. However, higher relative abundances of distinct taxa such as 
Propionibacterium, Corynebacterium, and Staphylococcus were once again observed 
in male subjects while Lactobacillus was over-represented in females. Interestingly, 
Enhydrobacter and Deinococcus also made up a large portion of female hand 
communities, while Fierer, et al, found no such contribution in either sex. This 
suggests that geographical or cultural aspects may also play a large role in 
diversifying skin microbial communities, a concept that has been supported by a 
number of additional reports as well [30,31].  
 
In a study comparing the skin microbiota at varying developmental stages, males 
and females between the ages of 2 and 40 were swabbed at the antecubital and 
popliteal fossae, the volar forearm, and the nares [32]. In all, no significant 
differences were observed between the bacterial communities of males and females 
regardless of age group. Moreover, a study comparing the levels of 
Propionibacterium and coagulase negative Staphylococcus in middle-aged men and 
women found no significant differences at the forehead, cheek, upper chest, or back 
[33]. However, it was found that males harbored greater total amounts of the fungi 
Malassezia.  
 
Studies have also examined the human axilla, upper buttock, forehead, and forearm 
as potential sites of gender variability. Interestingly, the bacterial communities of 
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the axillary vault were found to stratify into two main groups, those colonized 
predominantly by Staphylococcus and those with high relative abundances of 
Corynebacterium [34]. While not absolute, female subjects were generally found 
within the Staphylococcus cluster whereas males were more often associated with 
the Corynebacterium cluster. Analysis of the upper buttock also exhibited a strong 
effect of gender with males illustrating relatively high proportions of 
Corynebacterium, Dermacoccus, Streptococcus, and Finegoldia while females 
displayed elevated levels of Lactobacillus, Propionibacterium, Staphylococcus, and 
Enhydrobacter [35]. Despite these distinctions, there were no significant differences 
between genders when taking the entire microbial community into account, 
suggesting that individualized signatures were still the best indicators of variability.    
 
On the forehead, males and females were found to harbor differences in overall 
bacterial diversity [17]. However, when accounting for the use of make-up, 
significant variability between these groups was no longer detected. In contrast, 
microbial diversity of the forearm was significantly different between men and 
women at both the genus and species level.  
 
In all, it appears that gender may contribute to microbial community structure, but 
that the importance of this factor likely varies in a site-dependent manner. As male 
and female physiology differs throughout the body, it is not surprising that the 
contribution of gender to microbial communities is also inconstant. More detailed 
studies will be necessary to determine the importance of potential driving factors, 
 24
as no studies to date have measured microbial populations and biochemical 
signatures in concert. 
 
2.4.3 Age  
The human skin begins to develop in utero during the first trimester of gestation, 
and by 34 weeks, a well-defined stratum corneum has formed [36]. In the weeks 
leading up to delivery, the epidermis further matures, and begins to resemble a 
competent adult-like barrier by week 40 [36]. Upon birth, the skin undergoes a 
number of rapid changes as it acclimates to a dry, gaseous climate very much at 
odds with its former aqueous environment. During this time, the skin is 
characterized by quantal bursts of improved barrier function that persist for 
multiple weeks postnatal delivery [38]. Development then continues during the first 
year, after which point infant skin begins to resemble that of mature adults [39]. 
 
During maturation, infant skin is defined by a thin layer of corneocytes that are, on 
average, much smaller than adult corneocytes [40]. In addition, infant skin contains 
lower lipid content resulting in an epidermal barrier with higher water levels and 
increased permeability [39,41]. Neonates are also born with a relatively alkaline 
skin pH that remains less acidic than adult skin for the first two years of life [42]. 
 
All of these developmental features likely contribute to the differences seen 
between adult and infant bacterial communities. For example, Staphylococcus 
species, which are known to predominate at moist body sites on the adult 
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epidermis, have been found at significantly higher levels on neonatal skin. In fact, a 
recent study of the infant microbiota observed that Staphylococcus and 
Streptococcus species could account for up to 40% of skin bacterial populations 
during the first six months of life, before giving way to a more diverse community 
[43]. Interestingly, site-specificity also began to appear within the first few months 
of life. Staphylococcus, Streptococcus, Corynebacterium, and Propionibacterium were 
all found to predominate at the arm and forehead of infant skin while the buttock 
was colonized by both gut- and skin-associated taxa such as Clostridium, 
Staphylococcus, Streptococcus, and Ruminococcus. This suggests that as the skin 
matures, it becomes more adept at influencing resident bacterial communities at 
certain body sites.  
 
Additional experiments have also examined the route of delivery as a direct 
contributor to the human skin microbiota [44]. These analyses have shown that 
vaginally born neonates harbor skin bacterial communities very similar to those 
found in the vagina. This includes an abundance of both Lactobacillus and Prevotella. 
In contrast, babies born by Cesarean section were colonized by common skin 
residents such as Acinetobacter, Bacillales, Micrococcineae, and Staphylococcus. 
Interestingly, this study also found that babies born through conventional methods 
displayed skin bacterial communities most similar to their mother’s microbiota, 
while babies born by Cesarean section were no more similar to their own mother 
than any other subject. As such, while an initial vertical transmission of the bacterial 
microbiota existed in vaginally delivered neonates, no such transmission occurred 
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in babies delivered by Cesarean section. Rather it appears that incidental exposures, 
likely provided by hospital staff and environmental surfaces, were the greatest 
contributors to microbial communities in these subjects.  
 
While the initial inhabitants of infant skin can vary greatly depending upon age and 
delivery mode, their microbiomes appear to stabilize over time, reaching an adult-
like community at sexual maturity. A study employing Tanner staging to distinguish 
between children and adults found that the microbiota of subjects within Tanner 
stages 1, 2, and 3 segregated significantly from that of individuals at stages 4 and 5 
[32]. Similarly to above, it was also shown that higher levels of Proteobacteria and 
Firmicutes such as Streptococcaceae distinguished the microbiota of younger 
cohorts, while adolescents/post-adolescents were dominated by Propionibacterium 
and Corynebacterium. This particular result corresponds well with the 
developmental milestones reached at higher Tanner stages including elevated 
hormone levels and increased sebaceous gland activity, as both factors promote the 
growth of more lipophilic microorganisms [45].  
 
Interestingly, it has also been shown that the common fungal commensal Malassezia 
colonizes neonate skin during the birthing process [46]. At day 0 following delivery, 
Malassezia DNA was successfully detected in 24 of 27 subjects, and by day 30 
approximately 104 residents were estimated by qPCR. While the specific 
distribution of Malassezia residents differed greatly in newborns compared to their 
mothers, these rates stabilized to a level very near that of adulthood by day 30.  
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Overall, these results suggest that the skin and its microbial inhabitants develop 
together over time. While the physiological and biochemical attributes of the skin 
contribute a great deal to microbial diversity, this niche also represents a blank slate 
with the potential to accommodate a vast array of microbial organisms. For this 
reason, further research will be necessary to fully elucidate the dynamic nature of 
age-related succession.  
 
It may also be necessary to revise the long-held belief that most fetuses develop in a 
sterile environment. Recent evidence suggests that bacteria can be reproducibly 
isolated from newborn meconium and umbilical cords of healthy, full-term neonates 
[47,48]. Enterococcus faecium has also been isolated from newborn meconium and 
amniotic fluid following oral inoculation of pregnant mice, and fluorescent in situ 
hybridization can be used to visualize 16S rRNA-containing species deep within 
human fetal membranes [47-49]. A recent study of the placental microbiome also 
reported a diverse community of bacterial species characterized by increased levels 
of Proteobacteria [50]. In addition, both Gram-positive and Gram-negative 
intracellular bacteria have been detected in over a quarter of placental basal plate 
samples [51]. These findings are in stark contrast to the notion that newborns are 
not exposed to microorganisms until birth, and these microbes could contribute to 
the initial inoculum present on newborn epidermis.   
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2.4.4 Immune system 
The host immune system and the skin microbiota are in constant communication as 
each works to establish a steady equilibrium. This is not surprising given the 
intimate contact made between the two. In fact, it is thought that as many as 107 
bacteria/cm2 colonize the epidermis at any given time [52]. Although the vast 
majority of these microorganisms inhabit the stratum corneum, recent evidence has 
shown that bacterial species may also reside within deeper layers of the epidermis 
and dermis [35,53]. For this reason, it is essential for hosts to control the cutaneous 
immune response, and tailor it to a given threat, as persistent activation against 
resident skin bacteria could lead to chronic inflammatory disorders.  
 
To perform this function, the skin is equipped with a number of professional innate 
and adaptive immune cells including multiple dendritic and T cell subsets (Figure 
3). Keratinocytes also provide support through the expression of Toll- and Nod-like 
receptors and the secretion of antimicrobial peptides, proinflammatory cytokines, 
and chemokines [54]. Even melanocytes can assist in the overall immune response 
by recognizing and responding to specific foreign antigens [55]. 
 
While all of these cells play a crucial role in epidermal barrier function, Langerhans 
cells (LCs) are thought to act as the key initiators of cutaneous immunity by 
sampling the upper strata for microbial antigens and presenting these peptides to 
adaptive immune cells [56,57]. However, the exact role of these specific dendritic 
cells has recently come into question, as many of the tasks previously attributed to 
 29
LCs, such as cross-presentation, may actually be performed in vivo by a separate 
subset of myeloid cells known as dermal dendritic cells [58,59]. Regardless of 
subtype, it appears that dendritic cells are crucial to mediating the initial response 
to barrier disruption. Upon antigen uptake, these cells travel to cutaneous draining 
lymph nodes where they present foreign peptides to naïve T cells. These T cells then 
become activated and imprinted with skin-specific homing markers such as 
cutaneous leukocyte antigen (CLA), CCR4, CCR8, and CCR10 [60-63]. The ligands for 
these receptors are expressed at low levels during steady state, but they can be 
upregulated during inflammation, allowing for the recruitment of effector T cells to 
the skin epithelium. Upon antigen clearance, these mature T cells differentiate into 
resident or effector memory T cell subsets. Resident memory CD8+ T cells are then 
thought to remain within the epidermis while effector memory CD4+ T cells traffic to 
more distal sites of the skin [64,65].  
 
While this pathway has been established in response to infection, less information 
exists in regard to the skin’s response to commensal microorganisms. Specifically, it 
is currently unclear how the immune system can differentiate between pathogenic 
and non-pathogenic species, especially when considering the close proximity of 
keratinocytes, melanocytes, and LCs to conserved microbial antigens. A recent paper 
sheds some light on this debate by suggesting that LCs may perform separate roles 
depending on the state of epidermal tissue [66]. This group found that upon insult, 
resident LCs were crucial for the activation of resident memory T cells. However, at 
steady state, these cells promoted a homeostatic balance through the activation and 
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preservation of regulatory T cells. While it is proposed that these regulatory T cells 
are important for the maintenance of self-tolerance, this process could also regulate 
the host immune response to resident skin microorganisms and inhibit excess 
inflammation.  
 
With this in mind, various groups have explored the direct interactions of skin 
inhabitants with keratinocytes and the immune system. For example, the common 
skin commensal bacterium Staphylococcus epidermidis has been found to activate 
TLR2 signaling and the production of antimicrobial peptides and proinflammatory 
cytokines, augmenting the immune response to both group A Streptococcus and HPV 
infection [67-69]. The TLR2 ligand lipotechoic acid has also been shown to reduce 
TLR3-mediated inflammation in keratinocytes and promote the induction of 
cathelicidin-producing mast cells [70,71]. Interestingly, this effect does not appear 
to extend to macrophages, dendritic cells, or mouse endothelial cells, as exposure in 
these cell types results in an inflammatory response that is equal to or greater than 
that of epidermal keratinocytes. Therefore, a division of labor may exist within the 
cutaneous epithelium in which only certain cells can promote inflammation, a 
finding supported by the differential expression of Toll-like receptors at distinct 
layers of the epidermis [72].  
 
Our lab and others have also focused on the relationship between host immunity 
and skin bacterial residents in order to identify key members of this host-microbe 
interaction network. By treating mice with a C5aR antagonist, we have shown that 
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disruptions to the complement pathway can lead to significant changes in skin 
community structure including an increase in Actinobacteria and a decrease in 
Firmicutes [73]. We also observed a significant decrease in bacterial diversity 
(defined as the number of OTUs and their evenness), upon treatment, as well as a 
reduction in the overall number of bacterial OTUs. In addition, the expression of 
antimicrobial peptides, cytokines, chemokines, cell adhesion molecules, and pattern 
recognition receptors were all reduced in antagonist-treated mice, along with 
decreased levels of immune cell infiltration. This suggests that complement proteins 
may act to induce and/or maintain stable levels of these effectors, and that 
alterations to this balance can significantly shape skin microbial populations. The 
expression of complement genes in the skin of germ-free and conventionally-raised 
mice were also compared to determine the importance of bacterial stimulation to 
complement gene expression. In the absence of bacterial colonization, we observed 
significantly lower expression of over 30 genes related to complement activation 
and binding, indicating that both the skin and its resident microorganisms are 
capable of influencing the identity of their respective interaction partners.  
 
The ability of the immune system to shape bacterial communities has also been 
observed by comparing the skin microbiota of healthy and immunocompromised 
mice [74]. Here, it was found that healthy mice were colonized by an abundance of 
Proteobacteria including Acinetobacter, Escherichia/Shigella, and Acidovorax while 
immunodeficient mice were dominated by Firmicutes, especially those of the 
Staphylococcus genus. This difference was borne out in diversity metrics as well, 
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with healthy mice displaying a significantly greater degree of variation when 
compared to immunodeficient mice.  
 
Importantly, a recent study of humans with primary immunodeficiencies (PIDs) 
shows that this effect is not limited to murine models [75]. PID patients were 
defined by increases in microbial permissiveness to atypical microorganisms such 
as the opportunistic pathogen Serratia marcescens. Depending on the specific PID, 
patients were also characterized by decreases in site specificity, interpersonal 
variation, and longitudinal stability, suggesting a generalized dysbiosis caused by 
alterations to the host immune response. Paradoxically, these changes did not result 
in significant alterations to microbial diversity, however, indicating that site-specific 
restraints in humans may still control overall community structure.  
 
Work has also compared the adaptive immune systems of germ-free (GF) and 
specific-pathogen free (SPF) mice to determine the importance of commensal 
bacteria to cutaneous immunity [76]. This study found that skin bacterial residents 
influence T cell number and function, as GF mice had higher levels of Foxp3+ 
regulatory T cells and lower amounts of the cytokines IFN-γ and IL-17A. 
Importantly, this effect on IL-17A could be rescued by monocolonization with the 
skin commensal bacterium Staphylococcus epidermidis. These results were also 
extended to infection by the parasite Leishmania major. In this model, GF mice were 
unable to mount a robust immune response to L. major while monoassociation with 
S. epidermidis could restore protection in an IL-17A-dependent manner. IL-1α 
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expression was essential for this response, as neutralization of this cytokine 
impaired the restoration of IL-17A signaling. As such, it appears that IL-1 signaling 
pathways are enhanced by the skin microbiota, and that this response can promote 
overall skin immune fitness.  
 
A more recent report supports this finding by confirming the ability of T cells to 
shape skin bacterial communities [77]. Adoptive transfer of T cells from WT mice 
into Rag1-/- mice resulted in the rapid proliferation of both CD4+ and CD8+ T cells 
within skin draining lymph nodes, consistent with a memory immune response to 
skin bacterial antigens. The number of live bacteria and 16S rRNA bacterial 
sequences were also higher in Rag1-/- compared to WT mice, and the transfer of T 
cells from WT to immunodeficient mice resulted in a steady decline of these 
markers. This response was abrogated in the absence of IL-17A and IFN-γ, while B 
cell deficient mice mirrored WT phenotypes, suggesting that certain T cell profiles 
are essential for the recognition and control of skin bacterial residents.  
 
In all, these results indicate that the immune system and skin microbiota are in 
constant communication, and that each is necessary to promote homeostasis at the 
skin surface. However, these interactions appear to vary greatly depending on the 
specific immune cell subset and signaling pathway, and perhaps even the conditions 
in which mice are housed. Indeed one group recently reported no differences 
between the skin microbiota of healthy and immunocompromised mice, although 
variation is readily detectable when comparing the mice within different 
 34
experimental groups [78]. As such, further research will be necessary to describe 
the intimate relationship between hosts and bacterial inhabitants, and to determine 
the key players of this particular host-microbe interaction network.  
 
2.5 Host-microbiome interactions in cutaneous disease 
Many cutaneous disorders are caused by, or associated with, overt microbial 
infection. Here we focus on three of these disorders: acne vulgaris, psoriasis and 
atopic dermatitis. While complex in etiology, these conditions are thought to involve 
both microbial and host components. In addition, studies of these diseases have 
included deep sequencing approaches as a means to elucidate the contribution of 
skin microbial communities to disease pathology. As such, these disorders represent 
a model system to study the interactions of host factors and bacterial residents as 
they pertain to disruptions in skin homeostasis. 
 
2.5.1 Acne 
Acne vulgaris is one of the most prevalent skin diseases in the world, representing a 
financial burden of over 3 billion dollars per year in the United States alone [79]. 
Despite this figure and studies showing that acne can affect approximately 80% of 
adolescents and young adults [80], relatively little is known in regard to the events 
underlying this disorder. In particular, it remains unclear whether: (i) comedone 
formation is the cause or effect of inflammation in pilosebaceous follicles, (ii) which 
immune cells and cytokines drive the overall inflammatory response, and (iii) the 
specific role of skin microbial residents such as Propionibacterium acnes.  
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Over the past decade, a number of groups have begun to address these questions, 
outlining a multifactorial process driven, in large part, by increases in androgen 
production during puberty. This increase in hormone signaling activates sebaceous 
gland activity and induces epithelial hyperproliferation and keratinization [81]. 
These changes can then promote the colonization and growth of Propionibacterium 
acnes, and contribute to the chronic inflammation seen in affected pilosebaceous 
follicles.  
 
Multiple in vitro studies have demonstrated the ability of P. acnes to increase the 
expression of key inflammatory cytokines such as IL-1α, IL-1β, IL-6, IL-8, IL-12, and 
TNF-α by human sebocytes, keratinocytes, and monocytes [82-84]. The presence of 
infiltrating CD4+ T cells has also been observed by a number of groups, suggesting 
that the recruitment of these cells could promote inflammation within acne lesions 
[85-87].  
 
Recently, a number of independent reports confirmed the ability of P. acnes to 
upregulate the production of IL-1β through the activation of the NLRP3 
inflammasome [88-90]. Higher expression levels of NLRP3 and caspase-1 were 
observed in the areas surrounding acne lesions and both markers co-localized with 
infiltrating tissue macrophages [88,90]. Mice challenged with P. acnes also showed 
increased expression of caspase-1 and IL-1β, while NLRP3 knockout mice displayed 
a significant decrease in these inflammatory markers [89,90]. In sebocytes, this 
activity was dependent upon reactive oxygen species and P. acnes protease activity, 
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while monocytes required bacterial uptake, potassium efflux, and reactive oxygen 
species [88-90]. This information, coupled with studies showing increased 
expression of TLR-2 on acne-localized macrophages [83], suggests a mechanism by 
which monocytes are recruited to early acne lesions, and then activated by P. acnes 
to induce a more robust inflammatory response. 
 
Recent studies have also demonstrated the ability of P. acnes to stimulate Th17 
differentiation and activity. These reports have shown that IL-17-expressing cells 
often localize to affected pilosebaceous follicles and are elicited by the production of 
IL-1β, IL-6, and TGF-β [91]. In addition, P. acnes-reactive Th17 cells were isolated 
from the blood of acne patients at higher frequencies than those of healthy subjects 
[92]. Two commonly employed dermatologic acne treatments, all-trans retinoic acid 
and 1,25-dihydroxyvitamin D3, were also found to downregulate P. acnes-induced 
IL-17 mRNA and protein expression [91]. Together these results suggest that CD4+ 
Th17 cells may be key mediators of the chronic inflammation found within 
moderate-to-severe acne lesions, and that modulation of these cells could resolve 
certain aspects of P. acnes-induced pathology.  
 
While convincing, these results do not address the fact that P. acnes is a common 
skin inhabitant regardless of acne phenotype. Rather, reconciliation with this 
observation has come in the form of more detailed experiments describing the 
specific localization and genetic-signatures of individual P. acnes clones. These 
studies have shown that pilosebaceous follicles are more frequently colonized by P. 
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acnes in affected, compared to unaffected, individuals [93,94]. This bacterium is also 
found more commonly as macrocolonies within acne lesions in contrast to the 
sparse distributions that typically attach to the outer surface of the epidermis in 
healthy individuals [93,94]. Interestingly, within these follicles, multiple strains of P. 
acnes have been observed, but only certain strains, such as subtype IA, are 
associated with acne vulgaris [94-97]. A recent study utilizing 16S rRNA gene 
sequencing of P. acnes populations confirmed this finding by isolating certain 
subtypes of P. acnes from acne patients more frequently than others [98]. 
Interestingly, this group also reported a specific phylotype of P. acnes that 
associated more commonly with healthy subjects compared to acne patients, 
underscoring the importance of strain-specific profiles in P. acnes pathogenesis. 
 
Overall, it appears that androgen-induced increases in sebum production during 
puberty may promote P. acnes colonization, but that this effect is not necessarily 
emblematic of disease. Rather, the growth of specific P. acnes strains may be 
required for acne lesions to develop into fully mature papules and pustules. Indeed, 
studies have reported a differential immune response in sebocytes and 
keratinocytes when exposed to alternative strains of P. acnes, a characteristic that 
could explain the ubiquity of P. acnes in both affected and unaffected individuals 
[82,99].   
 
 
 
 38
2.5.2 Psoriasis 
Psoriasis is a common inflammatory disease affecting approximately 2-3% of the 
world’s population [100]. While multiple phenotypes exist, this condition is often 
characterized by well-demarcated erythematous plaques, resulting from chronic 
inflammation and the hyperproliferation of keratinocytes [101]. At onset, an initial 
inflammatory event is thought to precede plaque formation and induce the 
production of numerous proinflammatory cytokines. Further inflammation is then 
promoted by CD4+ Th1, Th17, and Th22 cells leading to distinct changes in skin 
architecture [102]. These include the thickening of epidermal cell layers, elongation 
of epidermal rete ridges, hypogranulosis, and parakeratosis [103].  
 
Genome-wide association studies have largely supported these phenotypic 
observations with most identified defects belonging to the IL-23/Th17 axis, NF-κB 
pathway, and epidermal differentiation complex [104-106]. However, the major 
genetic determinant of psoriasis is found within the HLA-Cw0602* allele of the MHC 
class I molecule, HLA-C [107]. Mutations within this locus are thought to account for 
approximately 60% of all psoriasis cases suggesting that CD8+ T cells may also play 
a major role in disease pathogenesis [108].   
 
Although a number of pharmaceutical drugs are currently available to mediate the 
inflammatory nature of psoriasis, little is known in regard to the source of this 
inflammation. Physical trauma (Koebner’s phenomenon) and infection have both 
been associated with the induction of psoriatic flares [109,110]. This is supported 
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by the observation that surgical procedures and streptococcal throat infections 
often precede lesion formation [103,111-113]. However, no study to date has 
identified an antigen capable of eliciting a complete psoriatic phenotype in healthy 
skin, despite links between superantigens and certain streptococcal surface proteins 
[114-116]. It is interesting to note that while infection of the throat with 
streptococcal species is the best-studied site of proclivity, Streptococcus is also a 
common resident of the skin [14-16]. As such, physical trauma and infection need 
not be mutually exclusive events if injury results in the presentation of 
streptococcal-associated (or alternative bacterial) antigens. 
 
In this vein, a number of groups have attempted to characterize the microbiota of 
psoriasis plaques in search of inflammatory antigens and disease-associated 
microbial signatures. The first of these found an overabundance of Firmicutes in 
psoriasis skin compared to uninvolved skin, while Actinobacteria were significantly 
underrepresented at affected skin sites [117]. Psoriasis plaque communities were 
also more diverse than unaffected skin with elevated 
Streptococcus/Propionibacterium ratios. Unfortunately, this particular analysis 
employed an unmatched study design, raising the possibility that observed 
differences could also be due to variation between microbial communities at distinct 
topographical sites.  
 
To address this concern, more recent studies have employed a matched control 
design that compares identical unaffected/affected skin sites. The first utilized skin 
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biopsies to study microbial populations on the trunk, arms, and legs of affected 
individuals [118]. This group found no differences in alpha or beta diversity 
between psoriatic and normal skin. Moreover, when taking body site into account, 
no differences were observed between Firmicutes or Actinobacteria species at the 
trunk or limbs. Proteobacteria were found to be significantly greater in trunk 
psoriasis samples compared to the control group, however this result was not 
significant when comparing the legs and arms of psoriasis subjects to controls. 
Similar to above, the ratio of Streptococcus/Propionibacterium was elevated in the 
psoriasis group with respect to controls, but this result was largely due to the 
absence of Propionibacterium in a number of psoriasis samples, rather than 
significant fluctuations in streptococcal species.  
 
More recently, Alekseyenko et al. compared swabs of psoriasis lesions to unaffected 
skin sites and demographically-matched controls [119]. While trending towards 
decreased alpha diversity, no significant differences in this metric were detected 
between lesions, unaffected sites, or control samples at the OTU level. There were 
also no differences in the relative abundances of Firmicutes or Actinobacteria. 
Notably, Proteobacteria were found at significantly higher levels in unaffected skin, 
in contrast to the abovementioned study. Plaque specimens also displayed the 
greatest intragroup diversity while unaffected skin from psoriasis patients was 
more similar to control skin. This suggests that psoriasis plaques may be more 
permissive to alternative phylotypes, while unaffected skin may retain its ability to 
influence microbial populations.  
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In all, these studies indicate that skin bacterial communities from affected subjects 
may be shifted in a modest, but significant manner. Given the intrapersonal 
variability of the microbiota at sites with disease predilection, it is also possible that 
stochastic differences between subjects are masking additional, more subtle trends. 
For this reason, longitudinal comparisons of subjects may prove more valuable as a 
means to survey the skin over time and monitor each individual with respect to 
his/her unique microbial community. This is especially important when considering 
disorders such as psoriasis, in which alterations to the microbiota appear less 
pronounced.   
 
2.5.3 Atopic Dermatitis  
Atopic dermatitis (AD) is a chronic inflammatory skin disease that affects 10-20% of 
the childhood population [120]. This condition initially appears as an eczematous 
rash with pruritis and erythema, but during later stages of disease these lesions can 
mature into lichenified plaques [121]. AD also predisposes individuals to increased 
prevalence of asthma, allergic rhinitis, and food allergies - a condition known as the 
“atopic march” [122]. Unlike psoriasis, AD is a CD4+ Th2-mediated disorder with IL-
4, IL-5, and IL-13 driving initial inflammatory events [123-126]. Upon sensitization, 
epidermal cells secrete pro-inflammatory cytokines such as thymic stromal 
lymphopoietin (TSLP), IL-25, and IL-33 [127-129]. This response then promotes a 
Th2-specific immune response which can lead to elevated infiltration by mast cells, 
eosinophils, and allergen-specific IgE [130-132].  
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Similar to the aforementioned conditions, the underlying cause of AD pathology also 
remains unclear. Although both immune dysfunction and epidermal abnormalities 
have been implicated by GWAS analyses, loci associated with cutaneous barrier 
function have been associated most strongly with the disease, specifically mutations 
in the filament-aggregating protein, filaggrin [133]. Filaggrin is a major structural 
protein of the epidermis that aligns keratin filaments and contributes to the 
contractile strength of the stratum corneum [134]. Over time, filaggrin is also 
broken down into natural moisturizing factors and amino acid derivatives to assist 
in the hydration and acidification of the stratum corneum [135]. As such, this 
protein represents an essential member of the epidermal differentiation complex.  
 
Because of the strong association between FLG mutations and AD, it is generally 
thought that disruptions to the epidermal barrier predispose the skin to allergen 
sensitization and immune dysfunction. However, this alteration in structure cannot 
fully explain the development of AD, as approximately 40% of patients with FLG 
mutations often fail to develop the characteristic lesions seen in affected individuals 
[136]. FLG expression can also be downregulated in patients with wildtype FLG 
alleles, suggesting that filaggrin levels and activity could be affected by peripheral 
means [137]. Indeed, exposure to the cytokines IL-4 and IL-13 can reduce 
expression of FLG, suggesting an alternative model in a subset of individuals 
whereby immune dysregulation could portend epidermal barrier abnormalities 
[138].  
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Interestingly, a number of studies also suggest that AD can promote colonization of 
the skin by Staphylococcus aureus. While S. aureus is a rather infrequent inhabitant 
of extranasal body sites in healthy individuals, it has been shown to colonize >80% 
of patients with AD [139-141]. In support of this, a recent study utilizing 16S rRNA 
gene sequencing found that Staphylococcus species, specifically S. aureus and S. 
epidermidis, dominated atopic lesions, while the common skin residents 
Corynebacterium, Streptococcus, and Propionibacterium were all significantly 
reduced [142]. The relative abundances of S. aureus were also correlated with AD 
disease severity, similarly to previous reports, indicating an increased propensity 
for S. aureus to colonize AD lesions [140,141,143].   
 
This increase in colonization has been hypothesized to occur for a number of 
reasons including a rise in the availability of S. aureus binding receptors, decreases 
in the expression of antimicrobial peptides (AMPs), and elevated levels of IL-4 
expression. In this regard, the lack of an intact stratum corneum in AD skin could 
expose extracellular matrix proteins to the surface and promote S. aureus 
colonization. Indeed, S. aureus adherence to the skin is reduced following 
preincubation with fibrinogen or fibronectin, and S. aureus strains lacking 
fibrinogen- and fibronectin-binding proteins illustrate significantly impaired 
binding to AD skin [144,145]. The cytokine IL-4 has also been shown to upregulate 
the production of fibronectin by dermal fibroblasts while binding of S. aureus to the 
skin is significantly impaired in IL-4 knockout mice [144,146].  
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Unfortunately, the importance of antimicrobial peptides to S. aureus colonization 
remains unclear. It was initially thought that reduced expression of AMPs in atopic 
skin could eliminate a key barrier to S. aureus colonization. In support of this, 
numerous studies have reported decreased expression of AMPs in AD-affected skin 
compared to that of psoriatic lesions [147-149]. However, more recent data 
comparing the levels of antimicrobial peptides in AD skin to that of unaffected 
controls has shown increased expression of multiple AMPs including RNase 7, 
psoriasin, hBD-2, hBD-3, and LL-37 [150,151]. Therefore, the previously ascribed 
reduction of AMPs in AD skin may be due more to the upregulation of these genes in 
psoriatic skin, rather than their decreased production in atopic individuals.   
 
In all, it appears that both barrier disruptions and improper immune activation 
contribute to lesions in AD patients. While the underlying cause of inflammation 
remains unclear, it is likely that this determinant involves a combination of genetic 
and environmental factors. Notwithstanding, AD pathology consistently leads to 
shifts in skin microbial communities including an increase in staphylococcal species 
such as S. aureus. While this observation is a satisfying explanation for the increased 
prevalence of S. aureus infections in AD patients, it is perhaps more striking that this 
rate is not higher [152]. S. aureus levels have been found to reach 107 CFU/cm2 in 
uninfected individuals [139,140], indicating that affected subjects may retain the 
ability to limit S. aureus pathogenesis despite a number of immune abnormalities. As 
such, a compartmentalized response in AD patients may exist, similarly to that seen 
in the gut, whereby atopic lesions can unintentionally promote the growth of S. 
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aureus at the skin surface while simultaneously opposing infection of the underlying 
tissues.  
 
2.6 Concluding remarks 
Advances in sequencing technology have enhanced our ability to characterize 
cutaneous microbial communities in a more precise and accurate manner, and as a 
result, our knowledge regarding host-microbe interactions in skin health and 
disease is steadily increasing. As these insights are deepened and developed, a 
major challenge will be to translate this knowledge into strategies that improve skin 
health and cutaneous diagnostic techniques. Future analyses employing shotgun 
metagenomics and metabolomics are essential to this goal, as we work towards a 
better comprehension of skin microbial population dynamics. Indeed a recent study 
of the skin microbiome utilizing metagenomic approaches has contributed greatly to 
our understanding of skin bacterial communities (153). Studies such as these are 
crucial to our perception of cutaneous microorganisms and can inform future 
experimental approaches. Only following these initial characterizations can we hope 
to truly appreciate the dysbiotic states associated with disease, and only then can 
we strive to successfully elucidate the importance of microbial inhabitants to 
hominal equilibria.  
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2.8 Figures 
 
Figure 1 Skin structure and morphology. The skin can be divided into two main 
layers, the epidermis (E) and dermis (D), and underlying regions of subcutaneous 
fat (SF). Hair follicles (HF) extend from the skin surface into the dermis and are 
often associated with sebaceous glands (SG). The epidermis contains distinct layers 
of keratinocytes at varying stages of development. Basal stem cells are found at the 
stratum basale while daughter cells mature to populate the stratum spinosum, 
stratum granulosum, and upon terminal differentiation, the stratum corneum. 
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Figure 2 Regional variation of skin microbial communities. The cutaneous 
microbiota varies according to body site and is strongly influenced by differences in 
cutaneous physiological environments. Each pie chart represents the mean bacterial 
community of a given biogeographic region. Sebaceous (red), moist (blue), and dry 
(green) regions are highlighted. Data from Grice et al. [13]. 
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Figure 3 Major skin immune cell subsets. Human skin is characterized by an array 
of innate and adaptive immune cells. In the epidermis, this includes Langerhans 
dendritic cells and CD8+ T cells. The dermis is home to a more varied population of 
innate dermal dendritic cells, NK cells, and mast cells, as well as adaptive CD4+ Th1, 
Th2, Th17, and Th22 cells. 
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CHAPTER 3 - Topical antimicrobial treatments can elicit shifts to 
resident skin bacterial communities and reduce colonization by 
Staphylococcus aureus competitors 
 
The contents of this chapter are under review for publication with the authors: 
SanMiguel AJ, Meisel JS, Horwinski J, Zheng Q, Grice EA. 
 
3.1 Abstract 
The skin microbiome is a complex ecosystem with important implications for 
cutaneous health and disease. Topical antibiotics and antiseptics are often employed 
to preserve the balance of this population, and inhibit colonization by more 
pathogenic bacteria. Despite their widespread use, however, the impact of these 
interventions on broader microbial communities remains poorly understood. Here 
we report the longitudinal effects of topical antibiotics and antiseptics on skin 
bacterial communities and their role in Staphylococcus aureus colonization 
resistance. In response to antibiotics, cutaneous populations exhibited an immediate 
shift in bacterial residents, an effect that persisted for multiple days post-treatment. 
By contrast, antiseptics elicited only minor changes to skin bacterial populations, 
with few changes to the underlying microbiota. While variable in scope, both 
antibiotics and antiseptics were found to decrease colonization by commensal 
Staphylococcus spp. by sequencing- and culture-based methods, an effect which was 
highly dependent on baseline levels of Staphylococcus. Because Staphylococcus 
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residents have been shown to compete with the skin pathogen S. aureus, we also 
tested whether treatment could influence S. aureus levels at the skin surface. We 
found that treated mice were more susceptible to exogenous association with S. 
aureus, and that precolonization with the same Staphylococcus residents that were 
previously disrupted by treatment could reduce S. aureus levels by over 100-fold. In 
all, this study indicates that antimicrobial drugs can alter skin bacterial residents, 
and that these alterations can have critical implications for cutaneous host defense. 
 
3.2 Introduction 
Antimicrobial drugs are commonly employed to inhibit the growth of pathogenic 
microorganisms. However, these interventions are rarely narrow in spectrum, 
instead acting on a range of bacterial species in our commensal microbiota (1). A 
number of studies have elucidated this effect in gut microbial populations, 
describing a dramatic reorganization of resident communities (2). This includes 
decreased bacterial diversity, and outgrowth by previously minor contributors (3-
5). Importantly, these alterations can persist for months to years post-treatment (6-
8), and also affect a number of host functions including metabolism, immunity, and 
transcriptional regulation (9, 10).  
 
Despite these findings, few studies have assessed the impact of antimicrobial drugs 
at alternative body sites such as the skin. Rather the majority of research at this site 
has been devoted to a subset of easily cultured microorganisms studied in isolation 
(11). This includes minimum inhibitory concentration tests of pathogenic skin 
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bacteria, as well as exogenous colonization studies in which non-resident, test 
microorganisms are applied to the skin prior to treatment (12). While these results 
are often applied more broadly, their main purpose is to inform the effect of 
antimicrobial drugs on transient, infectious bacteria, rather than more stable 
members of the community (13). As such, few studies have truly assessed the 
impact of antimicrobial drugs on inhabitant cutaneous populations. This dearth of 
research is especially notable given the frequency with which humans disrupt skin 
bacterial communities in both clinical and non-clinical settings. Indeed the intent of 
most antiseptics is to sterilize the skin by employing agents with non-specific 
mechanisms of action (14), with little regard for their effect on the resident 
microbiota. 
 
While culture-independent surveys have recently illuminated the complexity of the 
skin microbiota (15-17), its necessity for normal function and disease remains 
unclear. One postulated function includes a role in colonization resistance, whereby 
members of the commensal microbiota could protect the host from infection by 
opportunistic and pathogenic skin microorganisms (18). This particular process has 
been well-documented in the gut. Here numerous studies have highlighted the 
ability of bacterial residents to impair colonization by pathogenic bacteria through 
immune activation, nutrient exclusion, and the production of toxic metabolites (19). 
Antibiotics have also been shown to shift the resident microbiota, and render hosts 
more susceptible to certain pathogenic bacteria (20). This includes studies of the 
sporulating bacterium Clostridium difficile, which can recur repeatedly in response 
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to antibiotic treatment, but can also be controlled in most patients following the 
administration of fecal material from healthy, unaffected donors (21-23). 
Importantly, this particular effect is not isolated to C. difficile, as a number of 
bacterial pathogens including vancomycin-resistant Enterococcus and Salmonella 
enterica have been shown to exploit newly available niches in response to treatment 
as well (24-26).   
 
Similar to the gut, recent studies have begun to assess the potential for skin 
microorganisms to play a role in colonization resistance. This includes defense 
against Staphylococcus aureus by unique strains of S. epidermidis (27), S. lugdunesis 
(28), and most recently S. hominis (29). Here, it was found that certain individuals 
are colonized by host-specific Staphylococcus strains with the ability to alter S. 
aureus colonization patterns. While these studies also suggest that a removal of 
resident bacteria with antimicrobial agents could promote S. aureus colonization, no 
study to date has assessed this hypothesis in detail. Indeed, the long-term impact of 
topical antimicrobial drugs on skin bacterial communities, and their ability to alter 
colonization patterns by S. aureus competitors, remains largely unknown. 
 
Here we report this missing link by assessing the effect of antibiotics and antiseptics 
on the resident skin microbiota through a comparative time-series analysis. We 
report a differential impact of treatment on skin bacterial inhabitants, with the 
greatest disturbances elicited by a broad-spectrum triple antibiotic cocktail of 
bacitracin, neomycin, and polymyxin B. By contrast, we report a relatively muted 
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effect of antiseptics, with only modest alterations to overall bacterial community 
structure. Despite these differences, we identified a conserved decrease in the levels 
of Staphylococcus residents regardless of treatment, a result that was strongly 
influenced by baseline levels of Staphylococcus.  
 
Because commensal Staphylococcus spp. have been shown to impair colonization by 
the skin pathogen Staphylococcus aureus, we further evaluated this antimicrobial 
effect in the context of S. aureus colonization resistance. We show that treatment can 
promote exogenous association with S. aureus, and that the same Staphylococcus 
residents disrupted by treatment are also capable of S. aureus competition, 
decreasing S. aureus levels by over 100-fold in precolonization experiments. In all, 
our results demonstrate that antimicrobial drugs can elicit long-term shifts in skin 
bacterial communities, and that treatment with these agents has key implications 
for host susceptibility to pathogens such as S. aureus.  
 
3.3 Results 
3.3.1 Topical antibiotic treatment alters skin bacterial residents  
To assess the impact of topical antibiotics on the skin microbiota, we began by 
treating the dorsal skin of SKH-1 hairless mice twice daily for one week with the 
narrow spectrum antibiotic mupirocin; a broad spectrum triple antibiotic ointment 
(TAO: bacitracin, neomycin, polymyxin B); or their respective vehicles, polyethylene 
glycol (PEG) and petrolatum (Fig. S1a). In all, antibiotics led to durable changes in 
skin bacterial residents, with populations forming three distinct clusters (I – III) and 
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four sub-clusters (IIIA-D) (Fig. 1a). Interestingly, Clusters I and IIIA were composed 
largely of baseline and early time point samples high in Staphylococcus, while 
treatment with antibiotics led to sustained decreases in Staphylococcus (Fig. S1b) 
and alternative clustering patterns. Cluster II, by contrast, was composed almost 
entirely of TAO-treated mice, a group that exhibited significant increases in 
Enterobacteriaceae, Porphyromadaceae, and Ruminococcaceae, as well as 
significant decreases in Lachnospiraceae and certain taxa classified more generally 
within the Clostridiales family (Fig. 1b-d). This distinction led to a marked absence 
of TAO-treated mice from Clusters IIIB-D, and, similar to Staphylococcus, was 
sustained for multiple weeks post-treatment.  
 
Unlike TAO-treated mice, those administered mupirocin displayed community shifts 
largely in line with those treated with the vehicle PEG. Indeed while these mice 
exhibited significant increases in Alistipes and decreases in Oscillibacter and 
Staphylococcus (Fig. S1b, S1c), these minor changes were not enough to elicit 
separate clustering patterns amongst the two treatment groups. These particular 
changes also displayed similar kinetics to bacterial taxa in TAO-treated mice, i.e. 
immediate increases and sustained post-treatment effects, underscoring the 
difficulties faced by skin communities when attempting to re-acclimate upon 
treatment cessation.  
 
Analysis of bacterial burden revealed a contrasting effect of antibiotics on absolute 
abundance, with only mupirocin leading to the characteristic decreases often 
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associated with antibiotic treatment (Fig. S1d). TAO treatment, by contrast, resulted 
in increased bacterial burden suggesting that the elevated levels of 
Enterobacteriaceae and Porphyromonadaceae were due not just to increases in 
relative proportions, but also overall numbers.  
 
3.3.2 Topical antibiotics shift bacterial community structure 
To better quantify these results at the community-level, we next evaluated the 
diversity of bacterial populations over time. Similar to taxonomic analyses, we 
observed a relative stability in untreated mice and those treated with PEG, 
mupirocin, and petrolatum when testing alpha diversity metrics such as Shannon 
diversity, which takes into account the richness and evenness of taxa (Fig. 2a). By 
contrast, those treated with TAO exhibited an immediate and significant decrease in 
diversity starting after a single day (d1) of treatment, an effect that was maintained 
for greater than one week post-treatment. This was also recapitulated when 
evaluating community similarity by the weighted UniFrac metric, which assesses 
population differences based on abundance and phylogeny. When comparing each 
mouse to their baseline (d0) samples, we observed significantly greater differences 
within the TAO-treated group compared to vehicle-treated mice, a trend not shared 
by those administered mupirocin (Fig. 2b). Additional visualization of these samples 
by principle coordinates analysis further confirmed these results, as distinct 
clustering patterns were observed when comparing TAO-treated mice to other 
treatment groups (Fig. 2c).  
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Previously, others have shown similarities in the functional composition of a 
population despite differences in community membership and structure (30). To 
evaluate whether antibiotic treatment could lead to changes in the functional 
potential of skin inhabitants, we also utilized the PICRUSt software package (31) to 
infer metagenomic content of our populations. Specifically, PICRUSt analysis focuses 
on chromosomally-encoded, conserved differences amongst species as a method to 
approximate functional disparities. We found that treatment with antibiotics and 
vehicles led to a number of significant differences in genes associated with 
metabolism, signaling, transport, and biosynthesis, among others (Fig. S2). As such, 
the potential exists that by shifting the residents of the cutaneous microbiota, 
treatment may shift the functional capabilities of these populations as well.    
 
3.3.3 Antiseptic treatment elicits only modest changes to skin bacterial 
community structure 
Following our tests with antibiotic regimens, we next endeavored to evaluate the 
impact of antiseptics, a more promiscuous class of antimicrobials, on the skin 
microbiome. We reasoned that these topical interventions should provide an even 
greater impetus for community disruption due to their indiscriminate mechanisms 
and proven efficacy in clinical settings (14). To evaluate this hypothesis, we treated 
mice with the common clinical antiseptics alcohol (80% ethanol) or povidone-iodine 
(10%), and compared this to mice treated with water or untreated controls (Fig. 
S3a). Surprisingly, we observed no clustering of mice in response to treatment when 
taking into account major taxonomic groups (Fig 3a). Furthermore, when comparing 
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the relative abundances of individual taxa, we detected no significant differences 
among treated mice and untreated controls (Table S1). To evaluate whether subtle 
differences could contribute to a disruption at the population level, we also tested 
the diversity of communities in response to treatment. Similar to our taxonomic 
analyses, we found that antiseptic treatment resulted in no significant differences to 
Shannon Diversity (Fig. 3b), nor could we detect significant clustering by treatment 
using beta diversity metrics such as weighted UniFrac (Fig. 3c). To assess whether 
we had missed decreases in absolute abundance by focusing our analyses on the 
relative proportions of taxa, we also tested the impact of treatment on the bacterial 
load of communities. Once again, we observed no significant differences between 
treated and untreated mice (Fig. 3d), underscoring the stability of cutaneous 
bacterial communities in response to antiseptic treatment. 
 
As this result was particularly surprising, we further compared bacterial phylotypes 
at baseline to their d1 counterparts. This allowed us to evaluate whether treatment 
could shift populations in a conserved manner, thus explaining the modest effects 
seen between regimens at d1 post-treatment. However, when comparing the 
abundances of major taxonomic groups, we once again observed relatively few 
changes from d0 to d1 in response to treatment. Only Staphylococcus differed 
significantly, and only in response to alcohol treatment (Table S2). Interestingly, this 
effect was strongly dependent upon starting communities, as mice with higher 
baseline levels of Staphylococcus were more strongly disrupted than those with 
lower baseline levels, regardless of treatment (Fig S3b.). In all, this indicates that 
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antiseptics elicit a more muted response in skin bacterial populations, but that their 
effects may be dependent upon starting communities. 
 
3.3.4 Culture-based studies recapitulate sequence analyses of skin microbiota 
dynamics  
Our finding that most antiseptics elicited only minor changes to the resident skin 
microbiota was particularly surprising given the wealth of data describing their 
benefit in clinical settings. To address this discrepancy, we next sought to validate 
our findings using culturable skin inhabitants. Specifically, Staphylococcus was 
chosen as a proxy because of its established response to topical antimicrobials in the 
clinic and its importance to human health. These bacteria were also the only 
inhabitants to vary in response to both antibiotics and antiseptics in our sequencing 
experiments, and thus represented the best opportunity to verify our results in a 
culture setting.  
 
Because our antiseptic experiments exhibited an antibacterial effect dependent 
upon baseline communities, we began by designing a system to control 
Staphylococcus levels in murine populations. Specifically, we observed that mice 
housed in cages changed once per week displayed significant elevation in 
Staphylococcus levels (high Staphylococcus; HS) compared to those changed more 
frequently (low Staphylococcus; LS) (Fig 4a). When controlled over time, this effect 
could be maintained for multiple weeks and had the potential for reversibility, as 
mice swapped from frequent to infrequent cage changes rapidly converted to the 
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alternate phenotype. Cage change frequency and monitoring thus presented the 
opportunity to maintain Staphylococcus at distinct levels prior to treatment. 
 
To evaluate the impact of antimicrobial drugs on culturable Staphylococcus, we 
began by housing mice in cages with frequent or infrequent changes, and then 
treating with PEG, mupirocin, petrolatum, or TAO. Similar to sequencing 
experiments, antibiotic treatment led to a significant decrease in Staphylococcus 
starting at d1 post-treatment regardless of starting community, although this effect 
was more pronounced in LS mice (Fig. 4b,c). Interestingly, while we also observed a 
gradual decrease of Staphylococcus in response to PEG treatment, petrolatum-
treated LS mice displayed increased Staphyloccocus colonization at early time 
points, and elevated levels of Staphylococcus compared to untreated controls in HS 
mice. Because our sequencing results revealed similar decreases in Staphylococcus 
in response to treatment with antibiotics, but not petrolatum, this represents a 
reproducible mechanism in multiple testing protocols. 
 
To assess this effect in the context of antiseptics, a separate cohort of HS and LS 
mice were next treated with water, alcohol, or povidone-iodine, and compared to 
untreated controls. Unlike those treated with antibiotics, no significant differences 
in Staphylococcus were observed in LS mice following treatment with water, alcohol, 
or povidone-iodine compared to baseline colonization (Fig. 4d). Moreover, while HS 
mice were significantly decreased in Staphylococcus following treatment, untreated 
mice with a single cage change exhibited an almost identical reduction in 
 85
colonization, confirming that a change in environment can also have significant 
impacts on bacterial communities (Fig. 4e). In all, these experiments indicate that 
antibiotics and antiseptics have distinct effects on skin bacterial residents, and that 
the magnitude of this response can vary depending upon starting communities. 
 
3.3.5 Antimicrobial drugs reduce colonization by Staphylococcus aureus 
competitors 
After confirming our sequencing results with culture experiments, we next 
endeavored to explore the ramifications of cutaneous bacterial community 
disruption. As previous studies have suggested a role for the skin microbiota, and 
specifically resident Staphylococcus spp., in S. aureus colonization resistance (27-
29), we chose this particular commensal-pathogen pair for further analysis. We 
were particularly attracted by the ability of antimicrobial drugs to shift communities 
for multiple days post-treatment, suggesting a window in which S. aureus could 
access the skin unencumbered by competing residents or antimicrobial drugs. As 
alcohol was found to have relatively minor effects on skin bacterial residents, with 
the exception of Staphylococcus spp., we first tested whether treatment with this 
antiseptic could promote S. aureus association. Specifically, mice were treated with 
alcohol, similarly to previous experiments, and then exogenously associated with S. 
aureus one day post-treatment. As hypothesized, we observed a slight, but 
significant, increase in S. aureus levels in treated mice compared to untreated 
controls, indicating a reduction in colonization resistance in response to treatment 
(Fig. 5a).   
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Because this effect could also be the result of additional factors including previously 
unidentified microbial inhabitants, we next profiled individual Staphylococcus 
isolates that were reduced by antimicrobial treatment in our previous experiments. 
We reasoned that if these bacteria were the true source of colonization resistance, 
than adding them back to the skin should reduce S. aureus association in kind. 
Following phenotypic analysis and full-length 16S rRNA gene sequencing, we 
isolated five unique resident Staphylococcus genotypes – AS9, AS10, AS11, AS12, and 
AS17. Comparing these to reference sequences within the Ribosomal Database 
Project (RDP) (32), we identified four distinct species and two strain level variants: 
S. epidermidis (AS9), S. xylosus (AS10, AS11), S. nepalensis (AS12), and S. lentus 
(AS17) (Fig. 5b). Interestingly, while each of these bacteria fell within the 
Staphylococcus genus, they also had considerable genomic variability within the 16S 
rRNA gene region, suggesting a relative permissivity at the skin surface for these 
particular taxa (Fig. S4).  
 
To assess the colonization potential of each isolate, we next compared their growth 
dynamics under various conditions. When comparing growth in enriched media, we 
observed distinct differences amongst isolates, with AS17 S. lentus and AS10 S. 
xylosus displaying the most robust expansion kinetics (Fig. 5b). By contrast, AS9 S. 
epidermidis appeared to replicate the slowest and exhibited the most gradual 
exponential curve. AS11 S. xylosus and AS12 S. nepalensis both displayed 
intermediate growth patterns. To further evaluate colonization potential, we also 
applied each Staphylococcus isolate to murine dorsa every other day for 1 week to 
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promote monocolonization. Despite variable growth dynamics in vitro, all isolates 
colonized mice to an equal titer in vivo, suggesting conserved, undefined factors to 
promote colonization at the skin surface (Fig. 5c).  
 
As each of these isolates displayed notable colonization when added to murine 
hosts, we further tested all five to see whether they could also represent potential S. 
aureus competitors. To evaluate the ability of each isolate to restrict S. aureus 
colonization, we precolonized mice with each Staphylococcus resident prior to S. 
aureus challenge one day later. While isolates exhibited varying levels of 
competition, all resulted in significant decreases to S. aureus association compared 
to uncolonized mice (Fig. 5d). Indeed most mice exhibited greater than 10-fold 
reductions in S. aureus, and many, including those precolonized with S. epidermidis, 
were capable of decreasing S. aureus by levels greater than 100-fold. In all, this 
shows that skin bacterial residents can compete with S. aureus at the skin surface, 
and that their removal can impact S. aureus colonization potential.  
 
3.4 Discussion 
Given the expansive use of topical antibiotics and antiseptics, it is somewhat 
surprising that longitudinal studies to evaluate their effects on a community-wide 
scale are not more common. Here we report that antimicrobial drugs can elicit 
significant changes to skin bacterial community membership and structure, albeit to 
varying degrees. We also demonstrate that these alterations can have important 
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consequences for colonization resistance and the skin pathogen Staphylococcus 
aureus.  
 
Previous work has focused extensively on antibiotics and the gut microbiota. These 
studies have highlighted the ability of antimicrobials to disrupt bacterial 
communities and the consequences of these drugs on host physiology (33). One 
such example includes the elimination of colonization resistance leading to 
increased susceptibility to bacterial infections (34). By altering the structure of 
bacterial populations in the gut, antibiotics can shift the balance in favor of more 
infectious microorganisms (19). Clostridium difficile is perhaps the best-studied 
representation of this effect (35). However, additional pathogens such as 
vancomycin-resistant Enterococcus and Salmonella enterica can also exploit newly 
available niches and cause disease (36, 37). As a result, the true question has 
transcended beyond whether or not antimicrobial drugs can promote pathogenicity, 
to how best to mediate these unintended consequences. 
 
The first step in such ventures is the elucidation of antimicrobial effects on a 
community-wide scale. While studies of the gut have been vital to this endeavor, we 
present the skin as an additional body site worthy of consideration. In our 
investigations, triple antibiotic ointment (TAO) was found to provoke the greatest 
response in microbial residence, with a significant decrease in bacterial diversity 
and domination by previously minor contributors. While these changes originated 
as a result of treatment-specific effects, they often endured, and in some cases were 
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enhanced, following treatment cessation. This indicates that disrupted resident skin 
bacteria must undergo multiple levels of succession prior to community 
stabilization, similar to the gut (38).  
 
In accordance with their mechanisms of action, we also found the overall effect of 
mupirocin to be relatively minor compared to that of TAO. While TAO led to 
profound increases in bacteria from multiple families including Enterobacteriaceae 
and Porphyromonadaceae, mupirocin produced relatively minor shifts in less 
abundant taxa such as Alistipes and Oscillibacter. This finding is particularly notable 
as certain members of the Enterobacteriaceae and Porphyromonadaceae families 
have known intrinsic resistance mechanisms against TAO components such as 
polymyxin B (39, 40), a result that could also explain the increase in overall 
bacterial load seen in mice following TAO administration.  
 
Perhaps most surprisingly, we also report a relatively muted impact of antiseptics 
on the skin microbiota, with alcohol and povidone-iodine both failing to shift 
baseline communities in a significant manner. While it is tempting to explain this 
finding as an inability of 16S rRNA gene sequencing to distinguish between live and 
dead bacteria, we find this conclusion unlikely in the context of our studies and 
those before us. Indeed, our ability to detect differences in TAO-treated mice within 
one day of treatment provides strong evidence to the contrary. Others have also 
reported a similar community response to both decolonization protocols (41) and 
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mild and antibacterial soaps (42), confirming the stability of cutaneous populations 
in response to certain acute stressors.   
 
With this in mind, it is important to note that multiple studies have also shown a 
reduction of certain culturable skin inhabitants in response to antisepsis. This 
includes residents from the commonly studied genus Staphylococcus, often chosen 
for its ease of use in culture-based experiments (43, 44). In line with these findings, 
we also observed a decrease in Staphylococcus residents in our sequencing and 
culture studies. However, we note that because this bacterium was only one 
member of the larger community, this decline did not lead to shifts in overall 
population structure. 
 
Interestingly, Staphylococcus residents also exhibited baseline-dependent dynamics 
in response to antiseptic treatment during our sequencing experiments. Specifically, 
we observed that mice with high levels of Staphylococcus responded more readily to 
treatment than mice with low levels of colonization. This suggested a nuanced 
impact of antiseptics on certain bacterial inhabitants, whereby treatment effects 
could vary depending upon starting communities. To verify this hypothesis, we 
developed a system in which Staphylococcus could be tested for antimicrobial 
susceptibility at both high and low colonization levels. As anticipated, we found the 
efficacy of antiseptics to be highly dependent upon baseline communities. Mice with 
low levels of Staphylococcus at baseline (LS) exhibited little to no decline in 
Staphylococcus, while mice with high levels (HS) were reduced by approximately 
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100-fold. Importantly, we observed a similar effect in control HS mice, suggesting 
that higher levels of Staphylococcus are less stable in general, and thus represent 
atypical colonization. By contrast, the inability of antiseptics to reduce 
Staphylococcus in LS mice indicates a relative stability in this community, and a 
population capable of resisting the short-term stressors of antisepsis. We believe 
these studies have important implications for antimicrobial efficacy, particularly in 
the case of human skin, as humans are likely exposed to a greater number of 
transient microorganisms compared to laboratory mice housed in more controlled 
environments (45).   
 
When comparing antibiotic and antiseptic treatments, we observed that a standard 
course of antibiotics was more capable of community disruption than that of acute 
antisepsis. While these are the most commonly employed regimens in the clinic, 
further research should also evaluate the effects of long-term antiseptic treatments 
on the skin microbiota as well as other delivery mechanisms. Indeed the potential 
exists that consistent exposure to antiseptics through alternative means may have a 
more significant impact on skin inhabitants due to increased contact time or 
bioavailability. This is especially important when considering the rise of 
decolonization practices in the clinic, a procedure employing multiday, prophylactic 
antibiotic and antiseptic treatments to remove resident Staphylococcus species (46, 
47). While these methods efficiently remove endogenous S. aureus from the nares 
and extranasal body sites, they likely alter the underlying skin microbiota in kind. 
Without proper re-colonization, these interventions could feasibly elicit long-term 
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shifts to the skin microbiota, similar to our experiments, and promote infection by 
more dangerous hospital- and community-acquired pathogens (48-50). 
 
To assess this very possibility, we investigated the potential of treatment to 
promote S. aureus colonization at the skin surface in our mouse model. In response 
to treatment, we observed a significant increase in S. aureus levels compared to 
untreated controls following exogenous association, suggesting an increase in 
cutaneous permissivity. As previous studies have illustrated the role of certain 
Staphylococcus spp. to compete with S. aureus for colonization (27-29), we 
proceeded by testing the ability of murine Staphylococcus isolates to compete with S. 
aureus. Specifically, we chose Staphylococcus residents that were disrupted by 
antibiotic and antiseptic treatment in our previous experiments for further analysis. 
This allowed us to determine whether these particular bacterial residents were 
responsible for the decrease in colonization resistance, and to confirm the ability of 
antimicrobial drugs to alter communities with the potential for S. aureus 
competition. Importantly, we found that all isolates were capable of protecting 
against S. aureus association, with a number of mice exhibiting reductions in S. 
aureus levels by over 100-fold. These results support the notion that antimicrobial 
drugs can impact S. aureus colonization resistance, and argue for enhanced 
stewardship in the context of post-treatment recovery.  
 
In all, we describe the importance of antimicrobial drugs to skin bacterial 
community dynamics. By detecting unique changes in the microbiota in response to 
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topical antibiotics and antiseptics, we present the skin as a body site capable of 
reproducible disruptions and fluctuations in colonization resistance. For this reason 
and others, we further advocate for the judicious use of antibiotics and antiseptics, 
as well as increased monitoring of bacterial populations, in order to combat the 
unintentional consequences which can proceed cutaneous perturbations.  
 
3.5 Materials and Methods 
3.5.1 Mice  
Six-week-old female SKH-1 immunocompetent hairless mice were purchased from 
Charles River and acclimated for at least two weeks prior to testing. Throughout 
experimentation, mice were housed on ALPHA-Dri bedding and given ad libitum 
access to autoclaved food and water. Mice treated with the same antimicrobial drug 
or exogenous Staphylococcus strains were housed together to avoid mixing, and at 
least two cages were used per condition to assess caging effects. All cages were 
changed three to four times per week during the course of a study unless otherwise 
noted. All mouse procedures were performed under protocols approved by the 
University of Pennsylvania Institutional Animal Care and Use Committee. 
 
3.5.2 Antimicrobial treatment 
For experiments involving antibiotics, mice were treated on the dorsum with 
mupirocin (2% in polyethylene glycol) or a triple antibiotic ointment (Bacitracin 
400U, Neomycin 3.5mg, Polymyxin B 5,000U in petrolatum) every 12 hours for 7 
days. To control for any vehicle-specific affects, the control ointments for each 
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antibiotic were also used: polyethylene glycol (PEG 400, PEG 3350) and petrolatum. 
For experiments involving antiseptics, mice were treated on the dorsum with 
UltraPure water (MoBio), alcohol (80% ethanol), or povidone-iodine (Betadine, 
10%) every eight hours, three times total. At least three cages of three mice each 
were used for all conditions to evaluate caging effects.  
 
3.5.3 Bacterial DNA isolation and 16S rRNA gene sequencing and qPCR 
Cutaneous swabs were collected at baseline, during, and following treatment from 
mouse dorsa and stored at    −20 °C. Bacterial DNA was extracted as described 
previously (51). Briefly, Ready-Lyse Lysozyme solution (Epicentre), bead beating, 
and heat shock at 65 °C were used to lyse cells. The Invitrogen PureLink kit was 
used for DNA extraction. During our testing, the V4 region of the 16S rRNA gene was 
found to better approximate murine skin communities compared to V1V3. PCR and 
sequencing of the V4 region was thus performed using 150-bp paired end chemistry 
and barcoded primers (515F, 806R) on the Illumina MiSeq platform. Accuprime 
High Fidelity Taq polymerase was used for PCR cycling conditions: 94 °C for 3 min; 
followed by 35 cycles of 94 °C for 45 sec, 50 °C for 60 sec, 72 °C for 90 sec; and 
ending with 72 °C for 10 min. For bacterial load comparisons, 16S rRNA genes were 
amplified by qPCR using Fast SYBR Green Master Mix (Fisher Scientific) and the 
optimized primers 533F, 902R. Samples were compared to standard curves 
generated from known concentrations of serially diluted bacterial DNA to calculate 
burden.  
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3.5.4 Microbiome analysis 
Sequencing data was processed using QIIME 1.7.0 (52).  Briefly, sequences were de 
novo clustered into OTUs based on 97% similarity by UClust (53), and taxonomy 
was assigned to the most abundant representative sequence per cluster using the 
RDP classifier (54). Sequences were aligned by PyNAST (55), and chimeric 
sequences were removed using ChimeraSlayer (56) along with those identified as 
Unclassified, Bacteria;Other, or Cyanobacteria. Singletons were also removed in 
addition to any OTU found at greater than 1% abundance in at least 50% of control 
samples to eliminate potential contaminating sequences. All antiseptics, antibiotics, 
and vehicles were similarly sequenced and evaluated for possible contaminating 
sequences. All samples were rarified to 5,000 sequences, and samples below this 
cut-off were removed from downstream analyses. Alpha and beta diversity matrices 
were calculated in QIIME, and statistical analysis and visualization were performed 
in the R statistical computing environment (57). Heat maps were constructed by 
condensing all OTUs above 0.1% to the top 30 taxonomic identifications. The 
PICRUSt bioinformatics software package was used to infer functional content of 
bacterial communities (31).  
 
3.5.5 Caging effects 
Mice were housed three per cage, three cages per group, and cages were randomly 
assigned to be changed every other day (frequently) or once per week 
(infrequently) for four weeks. Swabs were taken every seven days prior to changes 
of the infrequent group, and cultured for Staphylococcus residents on Mannitol Salt 
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Agar (acumedia) overnight at 37 °C. At d28, mice from each cohort were reassigned 
to the alternate group, and swabbed for an additional four weeks to evaluate 
normalization.  
 
3.5.6 Antimicrobials and alternate Staphylococcus communities 
Mice were assigned to frequent or infrequent cage changes prior to treatment to 
generate low Staphylococcus and high Staphylococcus communities respectively, and 
treated as described above. During experimentation, all cages were changed on a 
frequent schedule with untreated mice representing controls. Swabs were taken at 
baseline, d1, d4, and d7 for antibiotic-treated mice, and at baseline and 4 hours post-
treatment for antiseptic-treated mice. Samples were cultured on MSA overnight at 
37 °C to enumerate Staphylococcus numbers.  
 
3.5.7 Staphylococcus isolation, sequencing, and phylogenetic tree 
To obtain a more complete profile of our Staphylococcus isolates, phenotypically 
distinct Staphylococcus colonies were picked from MSA plates following culture 
from murine dorsa prior to and following antimicrobial treatment. DNA was 
extracted from colonies as described above, and DNA was PCR-amplified using full-
length 16S rRNA gene primers (27F, 1492R). The primary PCR conditions used were 
98 °C for 3 min; 35 cycles of 95 °C for 45 sec, 56 °C for 60 sec, 72 °C for 90 sec; and 
72 °C for 10 min. Full-length 16S rRNA gene sequencing was performed by Sanger 
sequencing, and resident Staphylococcus isolates were compared to known 
Staphylococcus 16S rRNA genes downloaded from the RDP database (32). 
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Phylogenetic trees were generated by FastTree (58) and visualized in FigTree 
v1.4.3.  
 
3.5.8 Growth curves 
Staphylococcus isolates were grown at 37 °C in liquid Luria Broth (Fisher Scientific) 
for 12 hours shaking at 300 rpm. Samples were taken every hour and optical density 
was determined at OD600 using the BioTek Synergy HT plate reader. 
 
3.5.9 Exogenous Staphylococcus colonization and S. aureus competition 
Staphylococcus isolates were grown overnight in liquid Luria Broth (Fisher 
Scientific) at 37 °C and 300rpm. On the following day, isolates were subcultured and 
incubated to achieve log growth, and resuspended in PBS to acquire 108 CFU/ml 
inoculums. Titers were validated by culture and optical density measurements at 
OD600. Two cages of three mice each were monoassociated at the dorsum with 200ul 
of Staphylococcus isolate inoculum using a sterile swab. Application of 
Staphylococcus suspensions were repeated every other day over the course of one 
week for a total of four applications. Mice were then swabbed one day post-
association, and cultured on MSA overnight at 37 °C for CFU enumeration. S. aureus 
502A with selective streptomycin resistance was chosen for S. aureus competition 
studies because of its proven efficiency in skin colonization and potential for 
pathogenicity (59, 60). S. aureus was grown similarly to Staphylococcus isolates and 
applied one day post-treatment or one day post-monoassociation with individual 
Staphylococcus isolates. Control mice were administered PBS only. Mice were then 
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swabbed the following day for S. aureus, and cultured on LB agar with streptomycin 
for selective CFU enumeration. 
 
3.6 Accession numbers  
16S rRNA sequence reads have been deposited in the NCBI Short Read Archive 
under BioProject ID: PRJNA383404 
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3.9 Figures 
 
 
 
 
Figure 1 Topical antibiotics induce long-term shifts to skin microbial residents. (a) 
Heat map of rarified abundances for the 30 most common phylotypes on murine 
skin in response to treatment with polyethylene glycol (PEG), mupirocin, 
petrolatum, or triple antibiotic ointment (TAO). Dendrograms represent 
hierarchical clustering of Euclidean distances using complete agglomeration. 
Horizontal bars above the graph designate treatment and time point features for 
individual mice. (b-d) Breakdown and longitudinal analysis of rarified abundances 
for Enterobacteriaceae (b), Clostridiales (c), and Porphyromonadaceae (d). Data are 
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presented as mean ± s.e.m. Statistical significance was determined at each time 
point by Wilcoxon rank sum test (Mann Whitney U test). *P < 0.05, ** P < 0.01, *** P 
< 0.001, **** P < 0.0001.  
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Figure 2 Triple antibiotic ointment alters skin bacterial diversity. (a) Shannon 
diversity measurements of murine bacterial communities following treatment with 
antibiotics and vehicles over time. (b) Weighted UniFrac distances comparing 
longitudinal time points to baseline communities of bacterial residents in treated 
and untreated mice. (c) Principal coordinates analysis of weighted UniFrac distances 
for murine bacterial communities over time. Data are presented as mean ± s.e.m. 
Statistical significance was determined at each time point by Kruskal-Wallis rank 
sum test (a) or Wilcoxon rank sum test (Mann Whitney U test) (b). *P < 0.05, ** P < 
0.01, *** P < 0.001, **** P < 0.0001.  
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Figure 3 Antiseptic treatment induces only minor changes to skin microbial 
communities. (a) Heat map of rarified abundances for the 30 most common 
phylotypes on murine skin following treatment with water, alcohol, or povidone-
iodine. Dendrograms represent hierarchical clustering of Euclidean distances using 
complete agglomeration. Horizontal bar above the graph designates treatment for 
individual mice. (b) Shannon diversity of murine bacterial communities in response 
to treatment. (c) Weighted UniFrac principle coordinates analysis representing 
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differences in murine bacterial populations following treatment. (d) Bacterial load 
comparison of treated and untreated mice calculated by 16S rRNA gene content at 
the skin surface. Untreated (U), water (W), alcohol (A), povidone-iodine (P-I). 
Treatments were compared by Kruskal-Wallis rank sum test (b, d) or the adonis 
statistical test for community similarity (c). 
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Figure 4 Antimicrobial treatment alters resident Staphylococcus colonization in a 
baseline-dependent manner. (a) Murine resident Staphylococcus colony forming 
units (CFUs) in response to cage change frequency over time. Group 1 mice were 
changed every other day and Group 2 mice were changed once per week at the start. 
Groups were switched to the alternate regimen at d28. Data are presented with 
a
Group 1
Group 2
Change Frequency
d56d0 d7 d14 d21 d28 d35 d42 d49
Time Point
0
2
4
6
8
L
o
g
 S
ta
p
h
y
lo
c
o
c
c
u
s
 C
F
U
s
**** ***
*** ***
**** *** ***
***
Treatment
No Treat
PEG
Mupirocin
Petrolatum
TAO
0
2
4
6
8
Day
0 1 2 3 4 5 6 7
0
2
4
6
8
Day
0 1 2 3 4 5 6 7
Treatment
No Treat
PEG
Mupirocin
Petrolatum
TAO
L
o
g
 S
ta
p
h
y
lo
c
o
c
c
u
s
 C
F
U
s
L
o
g
 S
ta
p
h
y
lo
c
o
c
c
u
s
 C
F
U
s
**
**
††
††
††
**
††
††
**
††
b c
Baseline Post-TRX
0
2
4
6
8
L
o
g
 S
ta
p
h
y
lo
c
o
c
c
u
s
 C
F
U
s
Treatment
0
2
4
6
8
L
o
g
 S
ta
p
h
y
lo
c
o
c
c
u
s
 C
F
U
s
U W A P-I
Treatment
d e Baseline Post-TRX
U W A P-I
** ** ** **
n.s. n.s. n.s. n.s.
 105
median bars. (b, c) Murine resident Staphylococcus CFUs in response to antibiotic 
treatment starting at low (b) or high (c) baseline levels. Statistical comparisons 
were made between polyethylene glycol (PEG) and mupirocin (*) or petrolatum and 
triple antibiotic ointment (TAO) (†). Data are presented as mean ± s.e.m. (d, e) 
Murine resident Staphylococcus CFUs in response to antiseptic treatment starting at 
low (d) or high (e) baseline levels. Untreated (U), water (W), alcohol (A), povidone-
iodine (P-I). Statistical significance was determined by Wilcoxon rank-sum test 
(Mann Whitney U test). *P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001. 
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Figure 5 Resident Staphylococcus can reduce colonization by Staphylococcus aureus. 
(a) Staphylococcus aureus colony forming units (CFUs) following exogenous 
administration in mice pretreated with alcohol or untreated controls. (b) 
Phylogenetic tree of 16S rRNA gene diversity using approximate-maximum-
likelihood to compare murine Staphylococcus residents (red) to known 
Staphylococcus isolates from the RDP database (black). (c) Growth curve analysis of 
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resident Staphylococcus isolates at Optical Density 600 (OD600). (d) Enumeration of 
Staphylococcus isolate CFUs following exogenous administration to mouse dorsum. 
(e) S. aureus CFU levels following precolonization of mouse dorsum with resident 
Staphylococcus isolates. Data are presented as mean ± s.e.m (a) or with median bars 
(d, e). Statistical significance was determined by Wilcoxon rank-sum test (Mann 
Whitney U test).  *P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001. 
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3.10 Supplemental Figures 
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Supplemental Figure 1 Long-term alterations of select bacterial taxa in response to 
topical antibiotic treatment. (a) Schematic diagram of antibiotic treatments and 
sample collection regimen in mice administered polyethylene glycol (PEG), 
mupirocin, petrolatum, or triple antibiotic ointment (TAO). Treatment cohorts 
consisted of nine mice total, three cages of three mice each. Treatment occurred 
every 12 hours for one week, and mice were followed for 4 weeks post-treatment. 
(b,c) Longitudinal rarified abundances of (b) Staphylococcus and (c) Alistipes and 
Oscillibacter. (d) Variations in bacterial burden over time in response to treatment. 
Data are presented as mean ± s.e.m. Statistical significance was determined at each 
time point by Wilcoxon rank sum test (Mann Whitney U test). *P < 0.05, ** P < 0.01, 
*** P < 0.001, **** P < 0.0001.  
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Supplemental Figure 2 Changes to functional potential of bacterial communities in 
response to topical antibiotic treatment. Relative abundances of major KEGG 
Pathways calculated by PICRUSt analysis of bacterial populations following one 
week of treatment with polyethylene glycol (PEG), mupirocin, petrolatum, or triple 
antibiotic ointment (TAO). Data are presented as mean ± s.e.m. Statistical 
significance was determined for major pathway designations by Kruskal-Wallis rank 
sum test and FDR correction. *P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.  
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Supplemental Figure 3 Effects of antiseptics on skin bacterial inhabitants. (a) 
Model of antiseptic treatments and sample collection in mice treated with water, 
alcohol, or povidone-iodine. Treatment cohorts consisted of nine mice total, three 
cages of three mice each. Mice received three treatments total, one every 8 hours, 
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and were followed for one-week post treatment. (b) Rarified Staphylococcus 
abundance in response to treatment over time. 
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Supplemental Figure 4 Resident Staphylococcus isolate 16S rRNA gene sequences. 
Comparison of Sanger sequenced murine resident Staphylococcus 16S rRNA genes. 
Consensus sequence logo is notated above isolate sequences. Nucleotides with 
greater than 50% conserved identity are depicted in blue. Non-conserved 
nucleotides are unhighlighted.  
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3.11 Supplemental Tables 
Supplemental Table 1 Taxonomic comparisons of treatment groups at d1 post-
treatment. Significances calculated with FDR-corrected Kruskal-Wallis tests. 
Lineage FDR-
corrected 
p-value 
Actinobacteria; Actinobacteria; Actinomycetales; Microbacteriaceae  0.9263883 
Actinobacteria; Actinobacteria; Actinomycetales; Micrococcaceae; Kocuria  0.6638857 
Bacteroidetes; Bacteroidia; Bacteroidales; Porphyromonadaceae  0.6638857 
Bacteroidetes; Bacteroidia; Bacteroidales; Porphyromonadaceae; Parabacteroides  0.4254647 
Bacteroidetes; Flavobacteria; Flavobacteriales; Flavobacteriaceae; Chryseobacterium  0.6638857 
Bacteroidetes; Flavobacteria; Flavobacteriales; Flavobacteriaceae; Elizabethkingia  0.6638857 
Bacteroidetes; Flavobacteria; Flavobacteriales; Flavobacteriaceae; Flavobacterium  0.6486878 
Bacteroidetes; Sphingobacteria; Sphingobacteriales; Sphingobacteriaceae; 
Sphingobacterium  
0.1687431 
Deferribacteres; Deferribacteres; Deferribacterales; Deferribacteraceae; Mucispirillum  0.395196 
Firmicutes; Bacilli; Bacillales; Staphylococcaceae; Jeotgalicoccus  0.6638857 
Firmicutes; Bacilli; Bacillales; Staphylococcaceae; Staphylococcus  0.3879636 
Firmicutes; Bacilli; Lactobacillales; Enterococcaceae; Enterococcus  0.3879636 
Firmicutes; Bacilli; Lactobacillales; Lactobacillaceae; Lactobacillus  0.6638857 
Firmicutes; Bacilli; Lactobacillales; Leuconostocaceae; Weissella  0.6486878 
Firmicutes; Clostridia; Clostridiales  0.6638857 
Firmicutes; Clostridia; Clostridiales; Lachnospiraceae  0.6486878 
Firmicutes; Clostridia; Clostridiales; Lachnospiraceae; Dorea  0.3827328 
Firmicutes; Clostridia; Clostridiales; Lachnospiraceae; Johnsonella  0.649452 
Firmicutes; Clostridia; Clostridiales; Ruminococcaceae  0.4254647 
Firmicutes; Clostridia; Clostridiales; Ruminococcaceae; Oscillibacter  0.4254647 
Firmicutes; Clostridia; Clostridiales; Veillonellaceae; Veillonella  0.6486878 
Proteobacteria; Alphaproteobacteria; Sphingomonadales; Sphingomonadaceae; 
Novosphingobium  
0.1687431 
Proteobacteria; Betaproteobacteria; Burkholderiales; Comamonadaceae  0.6486878 
Proteobacteria; Betaproteobacteria; Burkholderiales; Comamonadaceae; Comamonas  0.6486878 
Proteobacteria; Betaproteobacteria; Burkholderiales; Oxalobacteraceae; Massilia  0.8707155 
Proteobacteria; Gammaproteobacteria; Enterobacteriales; Enterobacteriaceae  0.7751558 
Proteobacteria; Gammaproteobacteria; Pseudomonadales; Moraxellaceae; Acinetobacter  0.6638857 
Proteobacteria; Gammaproteobacteria; Pseudomonadales; Pseudomonadaceae; 
Pseudomonas  
0.1687431 
Proteobacteria; Gammaproteobacteria; Xanthomonadales; Xanthomonadaceae; 
Stenotrophomonas  
0.6486878 
Tenericutes; Mollicutes; Anaeroplasmatales; Anaeroplasmataceae; Anaeroplasma  0.6486878 
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Supplemental Table 2 Taxonomic comparisons of lineages at d0 and d1 post-
treatment. Significances calculated with FDR-corrected Wilcoxon rank sum tests. 
Treatment Lineage FDR-
corrected  
p-value 
Betadine Proteobacteria; Gammaproteobacteria; Pseudomonadales; 
Pseudomonadaceae; Pseudomonas 
1 
Betadine Bacteroidetes; Bacteroidia; Bacteroidales; Porphyromonadaceae 1 
Betadine Firmicutes; Bacilli; Bacillales; Staphylococcaceae; Staphylococcus 1 
Betadine Firmicutes; Clostridia; Clostridiales 1 
Betadine Firmicutes; Clostridia; Clostridiales; Lachnospiraceae 1 
Betadine Proteobacteria; Gammaproteobacteria; Xanthomonadales; 
Xanthomonadaceae; Stenotrophomonas 
1 
Betadine Firmicutes; Bacilli; Lactobacillales; Enterococcaceae; Enterococcus 1 
Betadine Bacteroidetes; Flavobacteria; Flavobacteriales; Flavobacteriaceae; 
Elizabethkingia 
1 
Betadine Proteobacteria; Gammaproteobacteria; Enterobacteriales; 
Enterobacteriaceae 
1 
Betadine Firmicutes; Clostridia; Clostridiales; Ruminococcaceae 1 
Betadine Bacteroidetes; Bacteroidia; Bacteroidales; Porphyromonadaceae; 
Parabacteroides 
1 
Betadine Bacteroidetes; Flavobacteria; Flavobacteriales; Flavobacteriaceae; 
Flavobacterium 
1 
Betadine Deferribacteres; Deferribacteres; Deferribacterales; Deferribacteraceae; 
Mucispirillum 
1 
Betadine Bacteroidetes; Sphingobacteria; Sphingobacteriales; Sphingobacteriaceae; 
Sphingobacterium 
1 
Betadine Bacteroidetes; Flavobacteria; Flavobacteriales; Flavobacteriaceae; 
Chryseobacterium 
1 
Betadine Proteobacteria; Betaproteobacteria; Burkholderiales; Comamonadaceae; 
Comamonas 
1 
Betadine Firmicutes; Clostridia; Clostridiales; Ruminococcaceae; Oscillibacter 1 
Betadine Firmicutes; Bacilli; Lactobacillales; Leuconostocaceae; Weissella 1 
Betadine Proteobacteria; Betaproteobacteria; Burkholderiales; Comamonadaceae 1 
Betadine Firmicutes; Bacilli; Bacillales; Staphylococcaceae; Jeotgalicoccus NA 
Betadine Proteobacteria; Alphaproteobacteria; Sphingomonadales; 
Sphingomonadaceae; Novosphingobium 
1 
Betadine Firmicutes; Clostridia; Clostridiales; Lachnospiraceae; Dorea 1 
Betadine Firmicutes; Bacilli; Lactobacillales; Lactobacillaceae; Lactobacillus 1 
Betadine Proteobacteria; Gammaproteobacteria; Pseudomonadales; Moraxellaceae; 
Acinetobacter 
1 
Betadine Tenericutes; Mollicutes; Anaeroplasmatales; Anaeroplasmataceae; 
Anaeroplasma 
1 
Betadine Firmicutes; Clostridia; Clostridiales; Lachnospiraceae; Johnsonella 1 
Betadine Actinobacteria; Actinobacteria; Actinomycetales; Micrococcaceae; Kocuria 1 
Betadine Actinobacteria; Actinobacteria; Actinomycetales; Microbacteriaceae 1 
Betadine Firmicutes; Clostridia; Clostridiales; Veillonellaceae; Veillonella 1 
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Betadine Proteobacteria; Betaproteobacteria; Burkholderiales; Oxalobacteraceae; 
Massilia 
1 
Ethanol Proteobacteria; Gammaproteobacteria; Pseudomonadales; 
Pseudomonadaceae; Pseudomonas 
1 
Ethanol Bacteroidetes; Bacteroidia; Bacteroidales; Porphyromonadaceae 1 
Ethanol Firmicutes; Bacilli; Bacillales; Staphylococcaceae; Staphylococcus 0.019744961 
Ethanol Firmicutes; Clostridia; Clostridiales 1 
Ethanol Firmicutes; Clostridia; Clostridiales; Lachnospiraceae 1 
Ethanol Proteobacteria; Gammaproteobacteria; Xanthomonadales; 
Xanthomonadaceae; Stenotrophomonas 
1 
Ethanol Firmicutes; Bacilli; Lactobacillales; Enterococcaceae; Enterococcus 1 
Ethanol Bacteroidetes; Flavobacteria; Flavobacteriales; Flavobacteriaceae; 
Elizabethkingia 
1 
Ethanol Proteobacteria; Gammaproteobacteria; Enterobacteriales; 
Enterobacteriaceae 
1 
Ethanol Firmicutes; Clostridia; Clostridiales; Ruminococcaceae 1 
Ethanol Bacteroidetes; Bacteroidia; Bacteroidales; Porphyromonadaceae; 
Parabacteroides 
1 
Ethanol Bacteroidetes; Flavobacteria; Flavobacteriales; Flavobacteriaceae; 
Flavobacterium 
1 
Ethanol Deferribacteres; Deferribacteres; Deferribacterales; Deferribacteraceae; 
Mucispirillum 
1 
Ethanol Bacteroidetes; Sphingobacteria; Sphingobacteriales; Sphingobacteriaceae; 
Sphingobacterium 
1 
Ethanol Bacteroidetes; Flavobacteria; Flavobacteriales; Flavobacteriaceae; 
Chryseobacterium 
1 
Ethanol Proteobacteria; Betaproteobacteria; Burkholderiales; Comamonadaceae; 
Comamonas 
1 
Ethanol Firmicutes; Clostridia; Clostridiales; Ruminococcaceae; Oscillibacter 1 
Ethanol Firmicutes; Bacilli; Lactobacillales; Leuconostocaceae; Weissella 1 
Ethanol Proteobacteria; Betaproteobacteria; Burkholderiales; Comamonadaceae 1 
Ethanol Firmicutes; Bacilli; Bacillales; Staphylococcaceae; Jeotgalicoccus 1 
Ethanol Proteobacteria; Alphaproteobacteria; Sphingomonadales; 
Sphingomonadaceae; Novosphingobium 
1 
Ethanol Firmicutes; Clostridia; Clostridiales; Lachnospiraceae; Dorea 1 
Ethanol Firmicutes; Bacilli; Lactobacillales; Lactobacillaceae; Lactobacillus 1 
Ethanol Proteobacteria; Gammaproteobacteria; Pseudomonadales; Moraxellaceae; 
Acinetobacter 
1 
Ethanol Tenericutes; Mollicutes; Anaeroplasmatales; Anaeroplasmataceae; 
Anaeroplasma 
1 
Ethanol Firmicutes; Clostridia; Clostridiales; Lachnospiraceae; Johnsonella 1 
Ethanol Actinobacteria; Actinobacteria; Actinomycetales; Micrococcaceae; Kocuria 1 
Ethanol Actinobacteria; Actinobacteria; Actinomycetales; Microbacteriaceae 1 
Ethanol Firmicutes; Clostridia; Clostridiales; Veillonellaceae; Veillonella 1 
Ethanol Proteobacteria; Betaproteobacteria; Burkholderiales; Oxalobacteraceae; 
Massilia 
1 
No Treat Proteobacteria; Gammaproteobacteria; Pseudomonadales; 
Pseudomonadaceae; Pseudomonas 
0.932949404 
No Treat Bacteroidetes; Bacteroidia; Bacteroidales; Porphyromonadaceae 1 
No Treat Firmicutes; Bacilli; Bacillales; Staphylococcaceae; Staphylococcus 0.148087207 
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No Treat Firmicutes; Clostridia; Clostridiales 1 
No Treat Firmicutes; Clostridia; Clostridiales; Lachnospiraceae 1 
No Treat Proteobacteria; Gammaproteobacteria; Xanthomonadales; 
Xanthomonadaceae; Stenotrophomonas 
1 
No Treat Firmicutes; Bacilli; Lactobacillales; Enterococcaceae; Enterococcus 1 
No Treat Bacteroidetes; Flavobacteria; Flavobacteriales; Flavobacteriaceae; 
Elizabethkingia 
1 
No Treat Proteobacteria; Gammaproteobacteria; Enterobacteriales; 
Enterobacteriaceae 
1 
No Treat Firmicutes; Clostridia; Clostridiales; Ruminococcaceae 1 
No Treat Bacteroidetes; Bacteroidia; Bacteroidales; Porphyromonadaceae; 
Parabacteroides 
1 
No Treat Bacteroidetes; Flavobacteria; Flavobacteriales; Flavobacteriaceae; 
Flavobacterium 
1 
No Treat Deferribacteres; Deferribacteres; Deferribacterales; Deferribacteraceae; 
Mucispirillum 
1 
No Treat Bacteroidetes; Sphingobacteria; Sphingobacteriales; Sphingobacteriaceae; 
Sphingobacterium 
0.388151273 
No Treat Bacteroidetes; Flavobacteria; Flavobacteriales; Flavobacteriaceae; 
Chryseobacterium 
1 
No Treat Proteobacteria; Betaproteobacteria; Burkholderiales; Comamonadaceae; 
Comamonas 
0.289846607 
No Treat Firmicutes; Clostridia; Clostridiales; Ruminococcaceae; Oscillibacter 1 
No Treat Firmicutes; Bacilli; Lactobacillales; Leuconostocaceae; Weissella 1 
No Treat Proteobacteria; Betaproteobacteria; Burkholderiales; Comamonadaceae 1 
No Treat Firmicutes; Bacilli; Bacillales; Staphylococcaceae; Jeotgalicoccus 1 
No Treat Proteobacteria; Alphaproteobacteria; Sphingomonadales; 
Sphingomonadaceae; Novosphingobium 
0.070091195 
No Treat Firmicutes; Clostridia; Clostridiales; Lachnospiraceae; Dorea 1 
No Treat Firmicutes; Bacilli; Lactobacillales; Lactobacillaceae; Lactobacillus 1 
No Treat Proteobacteria; Gammaproteobacteria; Pseudomonadales; Moraxellaceae; 
Acinetobacter 
1 
No Treat Tenericutes; Mollicutes; Anaeroplasmatales; Anaeroplasmataceae; 
Anaeroplasma 
1 
No Treat Firmicutes; Clostridia; Clostridiales; Lachnospiraceae; Johnsonella 1 
No Treat Actinobacteria; Actinobacteria; Actinomycetales; Micrococcaceae; Kocuria 1 
No Treat Actinobacteria; Actinobacteria; Actinomycetales; Microbacteriaceae 1 
No Treat Firmicutes; Clostridia; Clostridiales; Veillonellaceae; Veillonella 1 
No Treat Proteobacteria; Betaproteobacteria; Burkholderiales; Oxalobacteraceae; 
Massilia 
1 
Water Proteobacteria; Gammaproteobacteria; Pseudomonadales; 
Pseudomonadaceae; Pseudomonas 
1 
Water Bacteroidetes; Bacteroidia; Bacteroidales; Porphyromonadaceae 1 
Water Firmicutes; Bacilli; Bacillales; Staphylococcaceae; Staphylococcus 0.22213081 
Water Firmicutes; Clostridia; Clostridiales 1 
Water Firmicutes; Clostridia; Clostridiales; Lachnospiraceae 1 
Water Proteobacteria; Gammaproteobacteria; Xanthomonadales; 
Xanthomonadaceae; Stenotrophomonas 
1 
Water Firmicutes; Bacilli; Lactobacillales; Enterococcaceae; Enterococcus 1 
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Water Bacteroidetes; Flavobacteria; Flavobacteriales; Flavobacteriaceae; 
Elizabethkingia 
1 
Water Proteobacteria; Gammaproteobacteria; Enterobacteriales; 
Enterobacteriaceae 
1 
Water Firmicutes; Clostridia; Clostridiales; Ruminococcaceae 1 
Water Bacteroidetes; Bacteroidia; Bacteroidales; Porphyromonadaceae; 
Parabacteroides 
1 
Water Bacteroidetes; Flavobacteria; Flavobacteriales; Flavobacteriaceae; 
Flavobacterium 
1 
Water Deferribacteres; Deferribacteres; Deferribacterales; Deferribacteraceae; 
Mucispirillum 
1 
Water Bacteroidetes; Sphingobacteria; Sphingobacteriales; Sphingobacteriaceae; 
Sphingobacterium 
1 
Water Bacteroidetes; Flavobacteria; Flavobacteriales; Flavobacteriaceae; 
Chryseobacterium 
1 
Water Proteobacteria; Betaproteobacteria; Burkholderiales; Comamonadaceae; 
Comamonas 
1 
Water Firmicutes; Clostridia; Clostridiales; Ruminococcaceae; Oscillibacter 1 
Water Firmicutes; Bacilli; Lactobacillales; Leuconostocaceae; Weissella 1 
Water Proteobacteria; Betaproteobacteria; Burkholderiales; Comamonadaceae 1 
Water Firmicutes; Bacilli; Bacillales; Staphylococcaceae; Jeotgalicoccus NA 
Water Proteobacteria; Alphaproteobacteria; Sphingomonadales; 
Sphingomonadaceae; Novosphingobium 
1 
Water Firmicutes; Clostridia; Clostridiales; Lachnospiraceae; Dorea 1 
Water Firmicutes; Bacilli; Lactobacillales; Lactobacillaceae; Lactobacillus 1 
Water Proteobacteria; Gammaproteobacteria; Pseudomonadales; Moraxellaceae; 
Acinetobacter 
1 
Water Tenericutes; Mollicutes; Anaeroplasmatales; Anaeroplasmataceae; 
Anaeroplasma 
1 
Water Firmicutes; Clostridia; Clostridiales; Lachnospiraceae; Johnsonella 1 
Water Actinobacteria; Actinobacteria; Actinomycetales; Micrococcaceae; Kocuria 1 
Water Actinobacteria; Actinobacteria; Actinomycetales; Microbacteriaceae 1 
Water Firmicutes; Clostridia; Clostridiales; Veillonellaceae; Veillonella 1 
Water Proteobacteria; Betaproteobacteria; Burkholderiales; Oxalobacteraceae; 
Massilia 
1 
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Chapter 4 - Topical treatment interventions elicit personalized and 
site-specific shifts in human skin bacterial communities 
 
The contents of this chapter are prepared for submission with the authors: 
SanMiguel AJ, Meisel JS, Horwinski J, Zheng Q, Bradley CW, Grice EA. 
 
4.1 Abstract 
The skin microbiome represents a significant contributor to cutaneous health and 
disease. This includes its roles in immune tolerance and defense against pathogenic 
microorganisms. Despite these critical functions, the impact of topical interventions 
meant to disrupt these communities remains poorly understood. In this study, we 
present the effects of three clinically-relevant antiseptics, alcohol, povidone-iodine 
(Betadine), and chlorhexidine, on cutaneous bacterial populations. We illustrate a 
proficiency of these treatments in altering skin bacterial communities, a result 
which was highly dependent on interpersonal and body site-specific signatures. We 
also show that the magnitude of this response can be influenced by both the identity 
and relative abundances of bacterial inhabitants. By comparing the effects of 
antiseptic regimens, we highlight the importance of antibacterial activity and 
mechanical clearance to treatment disruption. We also demonstrate the potential 
for pre-treatment communities to inform post-treatment response. In all, these 
results further our understanding of treatment-derived perturbations to the skin 
microbiota, and establish the ability of topical interventions to influence skin 
bacterial dynamics. 
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4.2 Introduction 
Skin represents a unique habitat, colonized by an equally unique set of 
microorganisms (1). Previous studies have analyzed these residents in-depth, 
describing a stable community distinguished by both inter- and intrapersonal 
differences (2, 3). This includes the skin’s ability to select for microbial residents at 
distinct biogeographic regions, each representing a niche with selective pressures 
that can influence cutaneous microbial inhabitance (4). A number of studies have 
also tested the importance of these residents to human health, underscoring their 
ability to educate the immune system and protect against pathogenic skin 
microorganisms (5-8). Together, these studies have highlighted the importance of 
the skin microbiota, and outlined its role in host cutaneous defense. 
 
In light of these findings, it is important to note that humans are constantly working 
to disrupt skin microbial communities in both clinical and non-clinical settings (9-
12). While antimicrobial agents are largely employed to reduce infection by 
pathogenic microorganisms (13-15), these treatments can also act on resident 
cutaneous species (16-18). This is especially true for antiseptics, a group of 
antimicrobial agents used specifically for their indiscriminate mechanisms of action 
(19, 20). Antiseptics are a mainstay of modern medicine, but have also infiltrated 
our daily lives in the form of gels, wipes, and sprays designed to sterilize host 
cutaneous surfaces (21-23). As the significance of skin resident microorganisms 
becomes increasingly apparent, assessing the impact of these treatments on the 
colonization dynamics of skin inhabitance becomes of equal importance. Indeed, we 
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and others have recently expounded the potential for altered skin bacterial 
communities to impact colonization by Staphylococcus aureus, while additional 
reports have identified their importance in cutaneous diseases such as atopic 
dermatitis (24-26). These studies have highlighted the significance of skin microbial 
residents, and necessitated further research into treatment-derived perturbations. 
 
To expand our knowledge in this regard, we present the first study to date of 
antiseptics on human skin bacterial populations using sequencing-based 
approaches. We show that treatment elicits a significant impact on skin 
communities that is both personalized and body site-specific. We also show that 
certain microorganisms are more likely to be perturbed than others, with both 
abundance and bacterial identity representing key predictors of this response. Upon 
deeper analysis, water was found to elicit a similar shift in bacterial communities 
compared to alcohol and povidone-iodine (Betadine), indicating a conserved effect 
of these interventions based on mechanical disruption. By contrast, we observed a 
minimal impact of chlorhexidine treatment on skin residents, an effect likely 
influenced by the ability of this antiseptic to kill, but not necessarily remove, 
bacterial markers. In all, these results further our understanding of bacterial 
dynamics at the skin surface, and outline the potential for topical treatments to 
disrupt skin bacterial residence.  
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4.3 Results 
Thirteen subjects, six females and seven males, were recruited to evaluate the 
effects of antiseptics on the skin microbiome. Treatments were applied to the volar 
forearm and the upper back to evaluate alternate skin microenvironments (dry and 
sebaceous, respectively), and each subject received identical treatments to control 
for interpersonal variability. Subjects received water and alcohol (80% ethanol) on 
contralateral body sites during their first series of visits, and povidone-iodine 
(Betadine) and chlorhexidine during their second series of visits. Swab specimens to 
analyze the microbiota were collected at baseline, prior to treatment, and post-
treatment for 72 hours to assess longitudinal dynamics. Treated body sites were 
also accompanied by adjacent, untreated control sites, while visits were separated 
by at least two weeks to allow for microbial equilibration. Specific treatment 
topography, timing, and subject demographics are provided in Fig. S1a and Table S1. 
In total, 71,167,526 16S rRNA gene reads (hypervariable regions 1-3) were 
sequenced. Following quality control and filtering, the final study cohort 
represented 1,456 samples rarified to an even depth of 4,500 sequences per sample.   
 
4.3.1 Baseline characteristics of study cohort 
To validate our methods, we started by characterizing the baseline communities of 
our study cohort. As previously reported (2, 4), we identified a strong impact of 
biogeography on the skin microbiota. Back communities were largely dominated by 
Propionibacteriaceae and Staphylococcaceae (Fig. 1a). By contrast, forearm 
communities were more permissive, hosting increased proportions of additional 
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taxa such as Streptococcaceae and Corynebacteriaceae, amongst others. Reflecting 
these community compositions, alpha diversity was significantly different between 
body sites, with the forearm exhibiting increased Shannon diversity, observed 
species, and equitability compared to the back (Fig. 1b). These metrics also 
highlighted the importance of interpersonal variability, as data points showed 
consistent grouping by individual when assessing diversity at both body sites. When 
comparing these communities at the population-level, prominent clustering of 
subjects and body sites was observed by both weighted and unweighted UniFrac 
metrics (Fig. 1c). Comparisons of baseline communities also identified interpersonal 
variability and site-specificity as the most significant contributors to variation, 
followed by time and body symmetry respectively (Fig. S1b, c). In all, these results 
confirm previous work, and highlight the unique nature of resident skin bacterial 
communities.   
 
4.3.2 Treatment elicits personalized shifts to skin bacterial community 
structure  
To begin our investigation of antiseptics and the skin microbiota, we compared 
baseline resident populations to communities at 1hr post-treatment. Using weighted 
UniFrac and principal coordinates analysis, we observed minimal clustering of 
samples in response to treatment at the forearm and back, with none eliciting a 
significant shift in bacterial population structure (Fig. 2a). Because interpersonal 
differences were the strongest contributors to variability at baseline, and could thus 
mask more subtle effects of our treatments, we also compared subjects’ post-
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treatment communities to their baseline controls. Using this method we detected a 
significant effect of both water and alcohol at the forearm for at least 6 hours post-
treatment, suggesting a personalized effect of these treatments on population 
structure (Fig. 2b). Indeed, while both treatments caused a more robust shift than 
that seen in adjacent controls, neither could promote bacterial communities to a 
state outside that of the broader study cohort (Fig. 2c). Comparisons of Shannon 
diversity and bacterial burden also confirmed these effects with alcohol eliciting 
significant decreases in diversity, and both water and alcohol decreasing overall 
bacterial load (Fig. S2a, b).  
 
To determine the specific taxa responsible for this shift, we next focused our 
analysis on the most abundant taxa seen at the forearm. Specifically, 
Corynebacteriaceae, Propionibacteriaceae, Streptococcaceae, and 
Staphylococcaceae were chosen, as they represented a mean relative abundance of 
approximately 70% in baseline samples. Similar to community level analyses, most 
taxa were not significantly altered despite consistent changes by these taxa in the 
majority of subjects in our study cohort (Fig. 2d). Indeed, only Streptococcaceae was 
significantly decreased in response to treatment at the forearm, although both 
Propionibacteriaceae and Staphylococcaceae were also disrupted in nearly all 
subjects. In all, these data suggest that certain treatments can elicit changes to skin 
bacterial communities, but that this effect is often masked by interpersonal 
variability. 
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4.3.3 Treatment results in decreases to skin bacterial membership 
We next investigated whether treatment could elicit more significant changes to 
skin bacterial membership by unweighted metrics, which are agnostic to the relative 
proportions of bacterial taxa. In contrast to weighted comparisons, these tests 
revealed a prominent shift in bacterial communities following treatment at both the 
forearm and back (Fig. 3a). Moreover, when comparing treated communities to their 
baseline controls, both the back and forearm were significantly disrupted by water, 
alcohol, and Betadine compared to adjacent controls (Fig. 3b). To evaluate the cause 
of this shift, we analyzed the effect of treatment on the total number of observed 
species. We found that changes to community membership were largely driven by a 
decrease in bacterial richness, with water, alcohol, and Betadine all significantly 
reducing the number of observed species compared to adjacent controls (Fig. S3a).  
 
To further investigate these results, we also tested the effect of treatment on the 
membership of individual bacterial families. We found that Corynebacteriaceae, 
Incertae Sedis XI, Micrococcaceae, Staphylococcaceae, and Streptococcaceae were 
the most prominently disrupted taxa at both the forearm and back (Fig. 3c, Fig. S3b). 
Moreover, when comparing the richness of these taxa at treated and adjacent body 
sites, we found that each of these families were significantly decreased at treated, 
but not untreated, areas of the skin (Fig. 3d, Fig. S3c). Interestingly, this effect did 
not extend to all highly abundant families, as Propionibacteriaceae remained largely 
unchanged regardless of treatment or body site. This suggests that certain bacteria 
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may be less susceptible than others when assessing treatment-derived alterations to 
bacterial membership. 
 
4.3.4 Chlorhexidine retains free bacterial DNA at the skin surface  
During these initial tests, we were particularly struck by the inability of 
chlorhexidine to elicit a significant shift in bacterial community membership or 
structure. This was especially surprising given its proven efficacy against pathogenic 
microorganisms in hospital settings (27). As chlorhexidine is known for its ability to 
cause allergic and dermatologic irritation in a subset of individuals (28), we 
wondered whether acute treatment could result in cutaneous changes that would 
allow for better binding of free DNA from dead bacteria. This would then explain our 
inability to detect changes in the skin microbiota following chlorhexidine 
application. To test this hypothesis, we evaluated a subset of our subjects for 
alterations in skin barrier function by transepidermal water loss (TEWL) in 
response to treatment. We reasoned that if chlorhexidine were to alter the skin, 
making it more likely to bind free DNA, we should observe an increase in TEWL 
similar to that seen in patients with atopic dermatitis and other dermatologic 
conditions (29, 30). Upon testing, however, we found no significant differences in 
TEWL when comparing treatments to each other, or to baseline controls at 1hr and 
6hr post-treatment (Fig. S4a). This suggests that acute treatment with chlorhexidine 
does not uniquely alter the integrity of the skin barrier.  
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Although we have previously shown that treatment with antibiotic ointment, a 
particularly adherent substance, has a minimal effect on the retention of dead 
bacterial DNA (24), we still wondered whether chemical properties inherent to 
chlorhexidine could be responsible for its lack of observed effect. To evaluate this 
question, we applied marker bacterial DNA to the skin of mouse dorsa, and tested its 
persistence following treatment with water, alcohol, Betadine, or chlorhexidine. 
Surprisingly, we observed a unique ability of chlorhexidine to retain free bacterial 
DNA at the skin surface, with the total amount of marker bacterial DNA exceeding 
that of other treatment regimens at 1hr post-treatment by over 10-fold on average 
(Fig. S4a, b). To test whether this effect could persist for multiple hours post-
treatment, we also evaluated the quantity of DNA at 6hr post-treatment. Similar to 
1hr time points, we found that mice treated with chlorhexidine retained more DNA 
at the skin surface compared to other regimens at this time point as well (Fig. S4c). 
These experiments suggest that our inability to detect differences following 
chlorhexidine treatment were likely due to a unique ability of this antiseptic to bind 
bacterial DNA to the skin surface, and not necessarily a deficiency in antibacterial 
activity.  
 
4.3.5 Treatment elicits convergence at distinct community types in a site-
specific manner 
Because distinct chemical properties of chlorhexidine could represent a 
confounding factor in our experiments, we next focused our investigations on water, 
alcohol, and Betadine treatments only. Specifically, we tested whether an 
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unsupervised approach to community analyses could identify a conserved microbial 
signature in post-treatment populations. Dirichlet multinomial mixture (DMM) 
modeling utilizes probability distributions to establish a prior of metacommunities 
(31). Clusters can then be generated based on the similarity of a sample to a given 
metacommunity. Using this approach, DMM models identified 8 distinct clusters at 
the forearm, with individual subjects often being dominated by a single community 
type (Fig. S5a, b). Despite these interpersonal differences, however, we observed a 
prominent convergence at DMM cluster 1 in response to all treatments, an effect 
that was not observed at adjacent body sites (Fig. 4a, Fig. S5c). DMM cluster 1 was 
differentiated by decreased bacterial diversity, specifically richness (Fig. 4b), 
confirming our finding that treatment can significantly disrupt bacterial 
membership. This particular cluster also displayed fewer taxon-specific indications, 
suggesting a normalization of bacterial residents in response to treatment (Fig. 4c). 
In contrast to the forearm, back communities did not converge on a single 
community type following treatment (Fig. S5d, e). However, we did observe a slight 
increase in low diversity clusters in certain instances (Fig. S5f). In all, these data 
verify that treatment can elicit reproducible changes to skin bacterial communities, 
but also underscore the importance of body site to calculations of resident stability. 
 
4.3.6 Highly abundant bacterial families are the greatest contributors to 
treatment-derived changes in skin bacterial communities 
Our initial analyses suggested that certain bacterial taxa were disrupted more 
significantly than others, an effect which could lead to the increased frequency of 
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DMM cluster 1 we observed immediately post-treatment. To assess this hypothesis, 
we next tested characteristics shown to influence variation in untreated settings. We 
reasoned that the most variable taxa in the absence of treatment were also the most 
likely to change in response to topical intervention. As previous analyses have 
identified intermediately abundant taxa as the most susceptible to temporal 
fluctuation (32), we started by assessing the baseline variance of these taxa in our 
study cohort. Specifically, we compared the variance of bacterial residents at 
adjacent, contralateral, and temporally-controlled body sites to their mean relative 
abundances. Similar to previous data, we observed a distinct second-order, power-
law relationship in skin bacterial residents, with intermediately abundant members 
varying the most in untreated, baseline communities (Fig. S6a). 
 
To test which taxa were specifically responsible for these shifts, we assessed 
baseline variance at the family level for each subject at the forearm and back. We 
found that Propionibacteriaceae, Streptococcaceae, Staphylococcaceae, 
Corynebacteriaceae, Micrococcaceae, and Incertae Sedis XI constituted the most 
variable groups in baseline communities (Fig. S6b, c). Interestingly, rather than 
representing only intermediately abundant taxa, however, these families were often 
the most abundant residents in our study cohort, and also the most likely to vary in 
response to treatment. To investigate this discrepancy more directly, we again 
compared the variance of baseline taxa to their mean relative abundances, but this 
time we further controlled for both interindividual differences and body site-
specificity. While we had previously observed a second-order relationship when 
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aggregating subjects and body sites, stratification resulted in a more nuanced effect, 
with the variance of taxa frequently plateauing when plotted against their mean 
relative abundances (Fig. 5a). Indeed, top taxonomic groups were often found to 
exhibit both the greatest levels of variance and the greatest mean relative 
abundances, especially in the case of Propionibacteriaceae. Together, these results 
suggest that intermediately abundant skin bacteria are the most likely to fluctuate at 
higher levels of comparison, but that predominant taxa are more variable when 
assessing personalized biogeographic regions.  
 
Following these analyses, we next tested whether taxonomic variation at baseline 
could be used as an indicator of post-treatment effects. Specifically, we compared 
the baseline variance of bacterial families to their mean response following water, 
alcohol, and Betadine treatments. We found that the taxa most likely to vary in the 
absence of treatment were indeed the most likely to be disrupted by topical 
intervention, with decreases in the relative proportions of most taxa being offset by 
increases in Propionibacteriaceae (Fig. 5b). Importantly, we also observed that 
interpersonal variability was a strong contributor to this trend, as subjects with low 
variation of a given bacterial family were also less likely to exhibit shifts by those 
members following treatment. This trend was recapitulated when comparing the 
mean relative abundances of taxa to their mean treatment response as well. Once 
again, the greatest differences were observed within the Propionibacteriaceae 
family, which was both the most abundant bacterial family and the most likely to 
increase following treatment (Fig. 5c). In all, these results indicate that both 
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abundance and variation in untreated controls can inform treatment-derived effects, 
but that bacterial identity is also an important variable when measuring overall 
community response. 
 
4.3.7 Body site specificity informs fluctuations of the most abundant bacterial 
taxa 
During these analyses, we noted that, unlike other taxa, Propionibacteriaceae 
increased in relative abundance following treatment of the back. We also found that 
a subset of subjects exhibited similar dynamics when Staphylococcaceae was their 
most abundant taxon. Because we observed a decrease in bacterial load following 
treatment in our previous analyses, these increases in relative proportions were 
unlikely to represent increases in absolute abundance. However, they did suggest a 
personalized response in which the most abundant taxon per subject was also the 
most likely to persist following treatment. To test this hypothesis, we compared the 
levels of each subject’s most abundant taxon at baseline to its mean relative 
abundance following water, alcohol, and Betadine treatment. We found that in all 
cases but one, the most abundant taxon at the back increased in relative proportions 
following treatment regardless of identity, indicating a distinct competitive 
advantage (Fig. 5d). To assess whether this effect was specific to the back, we also 
examined the most abundant residents at the forearm. Unlike the back, only three 
subjects displayed taxa at this body site with greater than 50% relative abundance. 
Despite these varying properties, however, we still observed an increase in the 
relative proportions of Propionibacteriaceae in multiple subjects following 
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treatment, although this effect was not absolute (Fig. 5e). Interestingly, this trend 
did not extend to all skin residents, as Corynebacteriaceae, Staphylococcaceae, and 
Streptococcocaceae all decreased in abundance at the forearm, regardless of status. 
These results verify that abundance can be used to predict treatment effects, but 
also highlight the importance of body site to these outcomes.   
 
4.3.8 Lowly abundant members of predominant bacterial families are the 
most likely to vary in response to treatment 
Our previous investigations outlined the importance of abundance and bacterial 
identity when assessing the effects of water and antiseptic stress. To build on this 
finding, we further asked whether relative abundance could be used to predict the 
fluctuations of all taxa, rather than just the most prevalent taxon per subject. Indeed, 
the mere fact that certain bacterial families were found stably at the skin surface, 
regardless of subject, suggested a degree of competitive advantage for a subset of 
residents. To assess this hypothesis, we began by partitioning OTUs into highly or 
lowly abundant groups based on an abundance threshold of 0.5% - a value chosen 
from the inflection point of OTU counts at baseline (Fig. S7a). We then investigated 
alterations to the membership of these bacteria in response to treatment. In all, we 
observed a significant decrease in the number of lowly abundant OTUs following 
treatment at both the forearm and back (Fig. 6a), an effect due in large part to 
decreases in Corynebacteriaceae, Incertae Sedis XI, Staphylococcaceae, and 
Streptococcaceae (Fig. 6b, c Fig. S7b, c). By contrast, when evaluating highly 
abundant OTUs, only Streptococcaceae at the forearm and Corynebacteriaceae at 
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the back were significantly reduced, a result which did not significantly decrease the 
total number of highly abundant OTUs. Similar to previous results, we also observed 
no significant differences in the membership of Propionibacteriaceae, regardless of 
abundance or body site. These findings confirm that bacterial identity represents a 
critical factor when evaluating skin resident stability, and underscores the 
importance of abundance to predictions of treatment response.   
 
4.4 Discussion 
The skin microbiota has proven essential to numerous functions in cutaneous health 
and disease (5-8). However, few studies have assessed our ability to disrupt these 
communities, or their dynamics following antimicrobial stress. Herein, we present 
the impact of topical antiseptics on human skin bacterial populations, and outline 
the importance of key variables to overall community response.  
 
When evaluating treatments at a comparative level, we found water, alcohol, and 
Betadine to have similar effects on skin bacterial residents. Rather than highlighting 
the antibacterial nature of alcohol and Betadine, these results appear to underscore 
the generalized qualities of certain topical interventions, namely their ability to 
reduce inhabitance by mechanical cleansing (19). This result has been particularly 
well-established in culture-based systems. Here, reports have outlined the ability of 
certain topical treatments to both kill, and remove, pathogenic microorganisms, 
with each feature playing an important role in infection control (33, 34). Mild, non-
antibacterial soaps are also used with the sole purpose of clearance, further 
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emphasizing the importance of this mechanism to skin hygiene and community 
disruption (35, 36).  
 
Unlike alcohol and Betadine, chlorhexidine was found to elicit only minor shifts in 
skin bacterial residence. Given the ability of this antiseptic to reduce infections in 
clinical settings (37), this suggested that chlorhexidine might work in a unique 
manner to kill, but not remove, bacterial markers from the skin surface. To test this 
hypothesis, we applied free bacterial DNA to mouse dorsa, and treated with water, 
alcohol, Betadine, and chlorhexidine. We found that chlorhexidine was uniquely 
proficient at retaining bacterial DNA at the skin surface, with significantly greater 
levels of DNA at both 1hr and 6hr post-treatment. Further research will be 
necessary to elucidate the precise mechanism by which chlorhexidine achieves this 
feat. However, it is interesting to note that chlorhexidine is a cationic molecule, 
distinguished by an ability to bind the epidermal surface for multiple hours post-
treatment (38). As such, the potential exists that this antiseptic may retain bacterial 
DNA through a dual interaction with skin keratinocytes and the negatively charged 
DNA backbone. 
 
While no study to date has investigated the impact of antiseptics on the human skin 
microbiota by sequencing, others have assessed the effects of hand-sanitizers and 
soaps (39, 40). These studies have largely supported culture-based tests, outlining 
the importance of conserved mechanisms to topical treatment response. For 
example, a recent study by Zapka, et al. found that water and hand washing elicited 
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similar alterations to the skin microbiota as alcohol-based hand sanitizers in most 
tests (39). We have also observed similar findings in murine skin communities, with 
water reducing levels of colonizing Staphylococcus in a similar manner to 80% 
ethanol and Betadine (24). A recent comparison of mild and antibacterial soaps has 
confirmed these results as well, showing minimal differences when comparing their 
impact on the colonizing levels of S. epidermidis (40). 
 
In addition to these findings, each of the abovementioned studies observed a 
relatively minor impact of treatment on skin bacterial communities. Given these 
results, it is perhaps unsurprising that we initially observed only modest differences 
in response to antiseptic stress. Only after controlling for personalization and body 
site-specificity could we observe the true impact of our treatment regimens. These 
results are further underscored by our finding that treatment often elicited the 
strongest effects in low-level inhabitants. Indeed, highly abundant species likely 
exist at a given skin niche due to an ability to resist both host-derived and acute 
external stressors. As the skin is often colonized by particular strains with temporal 
stability for years at a time (32, 41), this outlines a system by which multiple taxa 
can exist on the skin surface, but only a subset is uniquely adapted for long-term 
colonization. These observations pair well with previous, culture-based analyses. 
Here, highly abundant skin residents have been shown to persist in response to 
various treatments while transient, low-level bacteria often represent a less stable 
group of community inhabitants (42-44).  
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In addition to abundance, we also found that bacterial identity could influence 
treatment response, with lowly abundant species from top taxa often being more 
significantly disrupted than other skin residents. This finding underscores the 
ecological advantages seen in bacterial families such as Propionibacteriaceae, 
Staphylococcocaceae, Streptococcaceae, and Corynebacteriaceae. The prevalence of 
these taxa at baseline in most subjects highlights their ability to utilize conserved 
resources at and within the skin surface (45). Upon the introduction of treatment-
derived stressors, however, a generalized selective advantage is no longer enough, 
leading to the persistence of only the most resilient and well-adapted members of 
each group.  
 
Treatment-derived alterations were also observed to be dependent upon body site, 
with the back representing a more stable habitat than the forearm. However, when 
assessing the richness of predominant bacterial families, the back and forearm were 
both found to be susceptible to a loss of lowly abundant OTUs. This finding 
emphasizes the reproducibility of disruption in low level inhabitants, and illustrates 
the conservation of certain outcomes at distinct biogeographic regions. 
Interestingly, this result did not extend to all major taxa, as members of the 
Propionibacteriaceae family persisted regardless of body site. We believe this 
particular effect could be due to an inherent resilience of Propionibacteriaceae, or 
an increased abundance at deeper, newly exposed layers of the skin. Regardless, the 
persistence of this taxon likely represents a unique opportunity to thrive in the 
post-treatment setting.  
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In all, this study furthers our understanding of skin bacterial dynamics and 
elucidates the effect of topical treatments on cutaneous resident populations. While 
we observed a similar impact of water and certain antiseptics, we note that our 
studies were designed to assess the totality of skin residents in healthy individuals. 
As such, we caution against the application of these findings to clinical settings in 
which the dynamics of pathogen and commensal are highly skewed. Indeed, 
previous studies have described, in-depth, the utility of antiseptics in these 
particular environments (46-48). As our study assesses only the effect of acute 
stressors, we also advocate for further research into long-term treatment regimens. 
The potential exists that more lasting perturbations may elicit even greater shifts to 
skin bacterial communities, an important consideration when evaluating the nexus 
of host-microbial interactions.   
 
4.5 Materials and Methods 
4.5.1 Human subjects and sample collection. Thirteen healthy subjects aged 23-
30 (median:27, 6 females) and without chronic skin disorders were recruited to 
participate in a controlled skin antiseptic study (Table S1). To be eligible for 
participation, subjects were required to be greater than 21 years of age, and could 
not have taken oral or topical antibiotics within 6 months of their first visit. Subjects 
were swabbed at baseline and then administered one of four treatments for 1.5 
minutes. Each participant received water (UltraPure Distilled Water, Invitrogen) 
and alcohol (80% ethanol) on contralateral forearm or back body sites during their 
first visit series, and povidone-iodine (Betadine, 10% povidone-iodine)) and 
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chlorhexidine (chlorhexidine-gluconate 4%) during their second visit series (Fig. 
S1a). Visit series were separated by at least two weeks to allow for microbial 
equilibration. Following treatment, subjects were swabbed at 1hr, 6hr, 12hr, 24hr, 
36hr, and 72hr post-treatment at both treated and adjacent body sites. Swabbed 
regions were delineated by a skin marker to ensure that the same body site was 
swabbed at longitudinal time points. Subjects were instructed to refrain from 
showering for at least 12 hours prior to each time point. Protocols were approved 
by the Institutional Review Board of the University of Pennsylvania, and written 
informed consent was obtained for all study participants prior to sampling. 
 
4.5.2 Transepidermal water loss. Transepidermal water loss was measured in a 
subset of four subjects using a Tewameter TM300 (Courage+Khazaka, Cologne, 
Germany) according to the manufacturer’s instructions. Briefly, subjects were 
equilibrated for at least 10 minutes prior to testing. Noninvasive probes were then 
pressed to the skin at baseline, 1hr, and 6hr post-treatment with water, alcohol, 
Betadine, or chlorhexidine to measure changes in skin epidermal barrier function. 
Each process was repeated at both the forearm and back to assess differences by 
body site.   
 
4.5.3 Bacterial DNA isolation, 16S rRNA gene sequencing, and qPCR. Bacterial 
DNA was extracted as described previously (49) using the Invitrogen PureLink kit. 
PCR and sequencing of the V1V3 hypervariable region was performed using 300-bp 
paired end chemistry and barcoded primers (27F, 534R) on the Illumina MiSeq 
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platform. Accuprime High Fidelity Taq polymerase was used for PCR cycling 
conditions: 94 °C for 3 min; 35 cycles of 94 °C for 45 sec, 50 °C for 60 sec, 72 °C for 
90 sec; 72 °C for 10 min. For bacterial load comparisons, 16S rRNA genes were 
amplified by qPCR using Fast SYBR Green Master Mix (Fisher Scientific) and the 
optimized primers 533F, 902R. Samples were compared to standard curves 
generated from known concentrations of serially diluted bacterial DNA to calculate 
burden.  
 
4.5.4 Microbiome analysis. Sequences were preprocessed and quality filtered 
prior to analysis, and QIIME 1.7.0 was used for microbiome evaluation (50). Briefly, 
sequences were de novo clustered into OTUs based on 97% similarity by UClust 
(51), and taxonomy was assigned to the most abundant representative sequence per 
cluster using the RDP classifier (52). Sequences were aligned by PyNAST (53), and 
chimeric sequences were removed using ChimeraSlayer (54). Sequences with calls 
to Unclassified, Bacteria;Other, or Cyanobacteria were removed in addition to 
singletons. Antiseptics and negative controls were similarly sequenced and analyzed 
for possible contaminating sequences, with no OTUs being found at consistently 
high levels. All samples were rarified to 4,500 sequences, and samples below this 
cut-off were removed from downstream analyses. Alpha and beta diversity matrices 
and taxonomy tables were formulated in QIIME. Statistical analysis and visualization 
were performed in the R statistical computing environment (55).  
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4.5.5 Dirichlet multinomial mixture models. Subsampled OTU counts were 
aggregated at the highest level of taxonomic classification. Samples were separated 
by body site and spurious taxa in less than 1% of samples were removed. Clusters 
were generated separately on forearm and back samples using the R package 
Dirichlet Multinomial (v1.14.0), and community types for each body site were 
calculated based on absolute minima from Dirichlet components and Laplace 
approximations of model evidence (31). Samples were assigned to final community 
types based on posterior probabilities.  
 
4.5.6 DNA retention. C57BL/6 mice were bred and maintained in specific pathogen 
free conditions at the University of Pennsylvania. Eight to fifteen week old males 
and females were randomized to control for differences in age and gender, and each 
mouse was housed singly to avoid cross-contamination. Mice were shaved at the 
dorsum and acclimated for at least 2 days prior to experimentation. 5-6 ng/ul of 
extracted Escherichia coli DNA was applied to mouse dorsa and permitted to dry for 
1hr prior to treatment. Mice were then administered water, alcohol, Betadine, or 
chlorhexidine for 1.5 minutes, similar to human experiments, and swabbed at 1hr 
and 6hr post-treatment. Following sample collection, DNA was extracted using the 
Invitrogen PureLink kit, and E. coli-specific DNA was amplified using qPCR primers 
to the ycct gene (56). Samples were compared to standard curves generated from 
known amounts of serially diluted E. coli DNA to calculate marker DNA 
concentrations.  
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4.6 Accession Numbers 
16S rRNA sequence reads have been deposited in the NCBI Short Read Archive 
under BioProject ID: XXXXXXXXXXX 
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4.9 Figures 
 
Figure 1 Skin bacterial communities exhibit site-specificity and interpersonal 
variability at baseline. (a) Family-level relative abundances of baseline communities 
for subjects at the forearm and back. Each bar represents an individual sample with 
eight samples per subject based on controls at adjacent and contralateral body sites 
for each visit series. (b) Alpha diversity of baseline communities at the forearm and 
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back. Shannon diversity, observed species, and equitability are illustrated 
separately. Each point is colored by subject. (c) Weighted (left) and unweighted 
(right) UniFrac principal coordinates analyses of baseline samples. Each point is 
colored by subject and shaped by body site. **** P < 0.0001 by Wilcoxon rank sum 
test (Mann-Whitney U test). 
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Figure 2 Treatment elicits personalized shifts in weighted comparisons of skin 
bacterial populations. (a) Principal coordinates analysis of weighted UniFrac 
distances for treated body sites at baseline and 1hr post-treatment. Each point 
represents a single sample, colored by treatment and shaped by body site. (b) 
Weighted UniFrac distances of subjects’ longitudinal time points compared to their 
individual baseline communities at treated and adjacent body sites. Points represent 
the median of participants. Error bars designate interquartile regions. (c) 
Subanalysis of weighted UniFrac distances visualized by principal coordinates 
analysis in subjects treated with water and alcohol at the forearm. Lines connect 
baseline and 1hr post-treatment samples for individual subjects, and line types 
designate treatment regimen. Line colors refer to treated body sites or their 
respective adjacent controls. (d) Comparison of relative abundances for the top 4 
taxa at baseline and 1hr post-treatment with water or alcohol. Each line represents 
an individual subject colored by an increase or decrease in relative abundance 
following treatment. * P < 0.05, ** P < 0.01 by Wilcoxon rank sum test (Mann-
Whitney U test). 
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Figure 3 Treatment results in distinct alterations to skin bacterial residents by 
unweighted metrics. (a) Visualization of unweighted UniFrac distances by principal 
coordinates analysis for treated body sites at baseline and 1hr post-treatment. Each 
point represents a single sample, colored by treatment and shaped by body site. (b) 
Comparison of unweighted UniFrac distances for baseline and post-treatment 
communities in response to treatment at the forearm and back. Points represent the 
median of participants. Error bars designate interquartile regions. (c) Difference 
between OTU counts for the top 25 families at the forearm for baseline and 1hr 
post-treatment samples in response to water, alcohol, and Betadine treatment. 
Points represent the median of participants and are colored by scaled differences in 
total count. Error bars designate interquartile regions. (d) Box and whisker plots of 
OTU counts for major taxa at adjacent and treated body sites of the forearm 
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between baseline and 1hr time points. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 
0.0001 by Wilcoxon rank sum test (Mann-Whitney U test). 
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Figure 4 Dirichlet multinomial modeling identifies convergence at distinct forearm 
community types following treatment. (a) Longitudinal frequencies of DMM clusters 
in response to treatment with water, alcohol, and Betadine. (b) Shannon diversity 
and observed species counts of individual DMM clusters. Data are presented as 
mean ± s.e.m. (c) Heat map of square root counts for the top bacterial taxa 
contributing to cluster identity. Dark bars correspond to greater counts. 
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Figure 5 Baseline variance and abundance are indicators of treatment-derived 
alterations to the skin microbiota. (a) Family-level comparison of the baseline 
variances (standard deviation) and mean relative abundances for subjects at the 
forearm and back. Each point represents the values for bacterial families of an 
individual subject, shaped by body site and colored by family. Lines connect families 
of an individual subject and body site. “Other” designations refer to any bacterial 
family different from the listed members (b) Baseline variance of bacterial families 
plotted against their mean treatment effect in response to water, alcohol, and 
Betadine treatment at the forearm and back. (c) Mean relative abundance of 
bacterial families at baseline compared to mean treatment effects at the forearm 
and back. (D, E) Mean difference in relative abundance of the most dominant taxon 
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per subject following treatment at the back (d) and forearm (e). Each point 
represents a single subject colored by bacterial family identity.   
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Figure 6 Lowly abundant members of prominent taxa are the greatest contributors 
to treatment effects at the skin surface. (a) Box and whisker plots of lowly and 
highly abundant OTU counts as defined by a 0.5% relative abundance threshold 
following treatment at the forearm and back. (b) Heat map of differences in forearm 
OTU counts between baseline and 1hr post treatment with water and antiseptics. 
Each column represents the difference measured for a single subject and treatment, 
and each row represents a bacterial family. Samples are clustered by the 
Unweighted Pair Group Method with Arithmetic means (UPGMA). Color-coded bars 
above the graph designate treatments for each sample. (c) Comparison of lowly and 
 163
highly abundant OTU counts at the forearm in major taxonomic families at baseline 
and 1hr post-treatment. Points represent the median of the study cohort. Error bars 
designate interquartile regions. * P < 0.05, ** P < 0.01, *** P < 0.001 by Wilcoxon 
rank sum test (Mann-Whitney U test). 
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4.10 Supplemental figures
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Supplemental Figure 1 Treatment regimen details and baseline community 
comparisons. (a) Diagram of sampling and treatment schedule for antiseptic study 
cohort. (b, c) Heat map of significances for weighted (b) and unweighted (c) UniFrac 
comparisons at the forearm and back for interpersonal, adjacent, contralateral, 
short-term (1hr), and long-term (visit) baseline community samplings.  
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Supplemental Figure 2 Alpha diversity and bacterial load are decreased in 
response to certain treatment regimens. (a) Longitudinal comparisons of Shannon 
diversity for bacterial communities at adjacent and treated body sites of the back 
and forearm. (b) Bacterial load at the forearm and back for treated and adjacent 
body sites over time. Data is presented by median points and interquartile regions. * 
P < 0.05, ** P < 0.01 by Wilcoxon rank sum test (Mann-Whitney U test). 
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Supplemental Figure 3 Treatment elicits decreases in bacterial richness. (a) 
Longitudinal measurements of observed species for adjacent and treated body sites 
at the back and forearm. Data is presented by median points and interquartile 
regions. (b) Difference between OTU counts for the top 25 families at the back for 
baseline and 1hr post-treatment samples in response to water, alcohol, and 
Betadine treatment. Points represent the median of participants and are colored by 
the scaled difference in total count. Error bars designate interquartile regions. (c) 
Box and whisker plots of OTU richness at the back for major taxa at adjacent and 
treated body sites between baseline and 1hr time points. * P < 0.05, ** P < 0.01, *** P 
< 0.001 by Wilcoxon rank sum test (Mann-Whitney U test). 
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Supplemental Figure 4 Effect of chlorhexidine on skin integrity and bacterial DNA 
retention. (a) Transepidermal water loss (TEWL) of subjects at the back and 
forearm in response to treatment with water, alcohol, betadine, and chlorhexidine. 
Each point represents an individual subject. Black bars denote median. (b-d) 
Concentration of marker bacterial DNA at (b) baseline, (c) 1hr, and (c) 6hr post-
treatment. Each point represents an individual mouse. Black bars denote median. 
Baseline refers to background concentrations of marker DNA prior to testing.  
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Supplemental Figure 5 Dirichlet multinomial mixture (DMM) model analysis for 
bacterial communities at the forearm and back. (a) Frequency of forearm DMM 
clusters by subject. (b) Laplace approximations for Dirichlet components of forearm 
communities. Global minimum is represented with a red point. (c) Frequencies of 
forearm DMM clusters at adjacent body sites over time. (d) Laplace approximations 
for Dirichlet components of back communities. (e) Longitudinal frequencies of DMM 
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clusters at the back for adjacent and treated body sites. (f) Shannon diversity and 
observed species counts of individual DMM clusters at the back. Data are presented 
as mean ± s.e.m. 
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Supplemental Figure 6 Variance of bacterial taxa at baseline. (a) Relationship 
between the mean relative abundances of bacterial families at baseline and their 
variance as measured by standard deviation. Each point represents a different 
bacterial family in an individual subject, shaped by body site. Data was fitted with a 
second-order curve to approximate taxonomic distributions. (b, c) Baseline variance 
of top 25 bacterial families at the back (b) and forearm (c). Points are colored by 
subject, and shaped by body site. Black bars represent median variance. 
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Supplemental Figure 7 Contribution of abundance to treatment-derived 
alterations in bacterial membership. (a) Sorted OTU abundances of all bacterial 
members in study cohort. Dashed red line represents 0.5% abundance threshold 
used to separate highly and lowly abundant OTUs. (b) Heat map of differences in 
bacterial family membership at the back between baseline and 1hr in subjects 
following treatment with water, alcohol, and Betadine. Each column represents the 
sample of an individual subject, and each row represents a bacterial family. Samples 
are clustered by the Unweighted Pair Group Method with Arithmetic means 
(UPGMA). Color-coded bars above the graph designate treatments for each sample. 
(c) Comparison of lowly and highly abundant OTU counts at the back in major 
taxonomic families at baseline and 1hr post-treatment. Data is presented by median 
a
b
c
Treatment
Water
Alcohol
Betadine
Corynebacteriaceae
Incertae Sedis XI
Propionibacteriaceae
Staphylococcaceae
Streptococcaceae
-40 -20 20 400-10 -5 0 105
StreptococcaceaeCorynebacteriaceae PropionibacteriaceaeIncertae Sedis XI Staphylococcaceae
TimePoint
0hr
1hr
0
20
40
60
80
100
L
o
w
ly
 a
b
u
n
d
a
n
t 
O
T
U
 c
o
u
n
t
* * * *** ** *** ** ** ** *
0
3
6
9
12
15
H
ig
h
ly
 a
b
u
n
d
a
n
t 
O
T
U
 c
o
u
n
t
W
at
er
Al
co
ho
l
B
et
ad
in
e
W
at
er
A
lc
oh
ol
Be
ta
di
ne
W
at
er
A
lc
oh
ol
Be
ta
di
ne
W
at
er
Al
co
ho
l
Be
ta
di
ne
W
at
er
Al
co
ho
l
Be
ta
di
ne
* * *
 174
points and interquartile regions. * P < 0.05, ** P < 0.01, *** P < 0.001 by Wilcoxon 
rank sum test (Mann-Whitney U test). 
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Chapter 5 - Conclusions and future directions 
 
5.1 Conclusions and future directions 
The results presented herein outline the impact of topical antimicrobial treatments 
on skin bacterial inhabitance. In our experience, a number of conflicting opinions 
exist in regard to skin bacterial dynamics. For example, it is not uncommon to 
question a group of researchers and find that some believe the skin microbiota 
exists as a stable resident community, while others assert its vulnerability to even 
minor perturbations. As is often the case in scientific endeavors, it appears as 
though the truth is likely complicated by circumstance, with neither view 
representing an adequate means to describe the intricacies of our cutaneous 
cohabitants.  
 
In support of this concept, we found antiseptics to elicit varying effects in skin 
bacterial residence. When assessing the impact of treatment on human subjects, we 
observed a reproducible decrease in lowly abundant bacteria. By contrast, highly 
abundant residents remained relatively stable over time. As highly abundant 
residents comprised the majority of cutaneous populations, community structure 
was largely preserved in response to treatment. However, changes to lowly 
abundant residents did represent the opportunity to identify personalized 
alterations in residence, shifts which were largely dependent on baseline 
populations. This result was also seen in murine studies in which housing 
conditions could influence baseline Staphylococcus levels, and the subsequent 
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magnitude of antimicrobial response. We did not observe a significant reduction in 
lowly abundant residents in these particular experiments, however, an effect we 
hypothesize may be due to mice being housed in clean environments with reduced 
exposure to transient bacteria.   
 
The ability of highly abundant residents to resist acute antiseptic stress is perhaps 
not altogether surprising. Indeed, when considering the dynamics of a community, it 
appears most likely that highly abundant taxa have attained this status by more than 
mere coincidence. Our results suggest that highly abundant bacteria represent a 
group of inhabitants uniquely adapted to an individual, while lowly abundant 
bacteria are more akin to transient passengers with a reduced capacity for 
persistence. If true, acute treatment-derived alterations may enable researchers to 
better interrogate host-microbial relationships, as they represent an opportunity to 
distinguish between long and short-term inhabitance.  
 
We find this proposition particularly attractive given the observation that certain 
taxonomic groups were more easily disrupted than others in our studies, specifically 
lowly abundant residents of top bacterial families. This points to the potential of the 
skin to select for specific classes of bacteria, while only the most well-adapted of 
each group may colonize stably over time. Indeed, without the competitive 
advantages of highly abundant taxa, lowly abundant residents are likely ill-equipped 
to survive most perturbations, resulting in their decreased residence in the post-
treatment setting.  
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With this in mind, our investigations educe two important questions. First, why 
some taxonomic families are better equipped than others to withstand acute 
stressors? And second, why certain members of these families are more capable of 
long-term colonization than others? The answer to each question is likely the result 
of both host- and microbial-derived features, with each contributing an important 
role in skin bacterial residence. 
 
We present Propionibacterium as a particularly salient example in this regard. As a 
lipophilic member of the skin microbiota, these residents thrive on the oily 
secretions produced by human sebaceous glands1. This, paired with their anaerobic 
preferences, results in a distinct localization of Propionibacterium to cutaneous 
structures with low levels of oxygen and high sebaceous gland activity2. During our 
experiments, both highly and lowly abundant members of this genus were capable 
of resisting treatment-derived alterations, leading to the possibility that 
Propionibacterium may be uniquely adapted to resist antibacterial perturbation. 
However, we find it equally likely that simply shielding themselves within 
cutaneous appendages could also contribute to this resident’s overall stability. 
 
With this in mind, we further note that Propionibacterium acnes strains have shown 
a wide array of stratification throughout the human population3. Traditionally 
thought of as the causative agent in acne vulgaris, certain strains of P. acnes are 
considered to be more pathogenic than others4. Certain individuals are colonized by 
these strains more readily than others as well5. This suggests that hosts play an 
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important role in the selection of their P. acnes strains, with each clone exhibiting 
unique competitive advantages over non-resident strains. Despite myriad 
treatments to combat this bacterium and reduce the overall number of P. acnes 
inhabitants, acne vulgaris remains a prevalent disorder in the developed world6. 
Based on our experiments, we would hypothesize that P. acnes clones may persist 
due to a unique ability to withstand acute interventions, and that certain treatments 
may even exacerbate this condition if they present resilient P. acnes strains with 
newly accessible niches.  
 
Similar dynamics can also be seen with the skin pathogen Staphylococcus aureus. As 
the most prominent cause of skin and soft tissue infections, S. aureus can establish 
long-term residence in a subset of individuals7,8. Host-specific strains can then cause 
a number of complications during surgery or other unplanned breaches of the skin9. 
To combat this effect, decolonization strategies have been advanced as a means to 
eliminate inhabitant S. aureus10. However, many of these studies have illustrated no 
significant reductions in overall infection11. We believe this phenomenon may occur 
as the result of S. aureus colonization’s dual nature in a host, with the ability to both 
precipitate infection while simultaneously protecting against it depending upon the 
circumstance.    
 
To support this hypothesis, we note that while decolonization can reduce S. aureus 
inhabitance, subsequent surgical infections can be accompanied by more severe 
complications12. This happens as the result of infection by non-resident S. aureus, a 
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result we propose may occur because of a loss in colonization resistance. Generally, 
bacterial infections within a hospital setting are caused by microorganisms with 
greater levels of resistance and increased virulence13,14. As such, the removal of 
colonizing S. aureus acquired in the community-setting could explain infection by 
these more harmful, hospital-associated pathogens. 
 
This principle has been well-established in the gastrointestinal tract. Here, 
Clostridium difficile, vancomycin-resistant Enterococcus, and Salmonella enterica are 
all capable of causing disease with increased frequency following antibiotic 
intervention15. Moreover, in the case of C. difficile, the administration of fecal 
material with potentially protective bacteria can lead to a resolution of disease16. 
These results indicate that antimicrobial treatment in the gut can reduce resident 
competition in a host, and increase susceptibility to infection and disease. 
 
To test the importance of this mechanism at the skin surface, we treated mice with 
antimicrobial drugs and assessed their impact on the skin microbiota. We observed 
a number of alterations in skin resident populations, including a conserved decrease 
in Staphylococcus membership regardless of treatment. As these experiments 
included the culture of pre- and post-treatment communities, we were able to 
identify the specific Staphylococcus residents disrupted by treatment. We could then 
pre-colonize mice with these same residents to evaluate their potential to compete 
with S. aureus at the skin surface. As hypothesized, each resident was found to 
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reduce association with S. aureus, underscoring the potential for the skin microbiota 
to exhibit colonization resistance features. 
 
While others have illustrated a similar ability of skin residents to compete with S. 
aureus17,18, our study represents the first to establish the role of antimicrobial drugs 
in this process. These results support the notion that a reduction in resident S. 
aureus may impact colonization resistance and infection in human patients as well. 
Further research is necessary to more completely evaluate this hypothesis, 
however. This includes an investigation of additional factors that can influence S. 
aureus residence, as well as studies outlining the importance of the human 
microbiota in this process. 
 
Because our studies only assess the impact of antimicrobial drugs on healthy skin, in 
the absence of infection or wounding, additional research should also examine the 
influence of these variables as they pertain to colonization resistance. The utility of 
antibiotics and antiseptics to improve patient outcomes has been expounded at-
length in these particular environments. However, little information exists in regard 
to the susceptibility of patients to infection in the post-treatment setting. Our work 
suggests that a window of susceptibility may exist during this time due to an 
inability of communities to re-stabilize for multiple weeks post-treatment. If this 
period includes impaired recolonization by protective skin residents, the potential 
exists that antimicrobial treatments could promote infection by new pathogens as 
well as recurrent strains. 
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Fortunately, the skin represents a body site with unique advantages to study these 
principles, namely an ability to apply competing residents directly to a site of 
interest. While less harmful bacteria can be taken orally to compete against 
pathogenic inhabitants of the gut, there is no guarantee that these bacteria will be 
able to access a particular niche. Indeed, many experiments have outlined the 
difficulties encountered by exogenously administered bacteria when attempting to 
establish long-term colonization of the gut19-21. As colonization is the first step in the 
majority of interference pathways, a deficiency at this stage understandably 
complicates the study of bacterial competition. 
 
Unlike the gut, skin represents an easy to access biological surface for colonization 
resistance studies. Indeed, one can apply varying concentrations of bacteria directly 
to the skin surface, and shift the equilibrium amongst any number of bacterial 
inhabitants. We provide one such example of these advantages in our own 
experiments. However, one could imagine the utility of these approaches when 
testing additional skin residents and pathogens for competition and colonization 
potential.  We suggest that future experiments employ these methods to further 
establish the mechanisms behind our particular findings, and extend these 
observations to additional models. 
 
Finally, we note that antimicrobial treatments varied in their ability to alter skin 
bacterial residence. As previously mentioned, the antiseptics alcohol and povidone-
iodine elicited relatively minor changes to bacterial population structure. Antibiotic 
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treatment, by contrast, resulted in disruptions that were both immediate and 
durable, with triple antibiotic ointment (TAO) shifting communities for multiple 
weeks post-treatment. TAO treatment also led to the outgrowth of previously minor 
contributors, underscoring the potential for alternative community states to 
predominate following antibiotic treatment. 
 
These results represent a number of opportunities for future investigation, with a 
subset mentioned herein. First, we recognize that antibiotic effects were largely 
agent-dependent, with TAO eliciting a more significant response than Mupirocin. 
This suggests that broad spectrum antibiotics have a greater impact on skin 
bacterial communities than those which target specific bacterial taxa. While this is 
to be expected, subsequent work should also explore the ramifications of narrow 
spectrum antibiotics that target more abundant skin residents. Indeed, the bacterial 
genera most disrupted by Mupirocin, Staphylococcus and Streptococcus, were found 
at relatively low levels in appropriately housed mice. As such, their removal would 
not necessarily be expected to result in large shifts to overall community structure.  
 
Second, we note that our antibiotic studies were performed only in murine hosts. 
Consequently, the impact of antibiotics on human skin residents remains largely 
unknown. If these drugs are capable of disrupting the human skin microbiota in a 
similar manner to mice, this could have a number of important implications for host 
cutaneous biology. Studies at alternate body sites have previously expounded the 
importance of bacterial residents to immune function and development22. Future 
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investigations should thus employ measurements of host gene expression and 
immune cell populations, in order to more completely characterize the 
consequences of skin bacterial perturbation. 
 
Third, because our experiments focused on topical antimicrobial treatments, the 
impact of oral antibiotics remains largely unknown. While oral antibiotics have the 
potential to disrupt both gut and skin communities, no study to date has rigorously 
explored the interplay between these systems. This would be especially compelling 
in the case of antibiotics available in both oral and topical formulations. Indeed, the 
potential exists that different routes of administration could have important 
implications for skin and gut bacterial inhabitance alike. 
 
As a final note, we recognize that our studies were performed using 16S rRNA gene 
sequencing for bacterial identification. While this was necessary to maximize the 
breadth of our comparisons, our studies have now outlined the optimal parameters 
for these types of analyses. Future work can thus build upon these findings by 
employing whole metagenome shotgun sequencing as a means to evaluate the 
effects of antimicrobial drugs on the functional potential of skin communities, and 
with strain-level resolution. These investigations will also be useful in determining 
the impact of antibiotics and antiseptics on non-bacterial residents. Indeed, while 
we have largely framed the question of antimicrobial effects as a “simple” matter of 
bacterial dynamics, fungal and viral populations are undoubtedly affected in kind.  
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In all, our studies outline the potential for antibiotics and antiseptics to alter skin 
bacterial residence. However, future research will be essential to a more complete 
understanding of this response. Our data underscore the potential for said 
endeavors to inform unique mechanisms of cutaneous health and disease, and it is 
our hope that studies such as these will result in a more prudent approach to 
antimicrobial use in clinical settings and beyond.  
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